<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosgen</journal-id><journal-title-group><journal-title>PLoS Genetics</journal-title></journal-title-group><issn pub-type="ppub">1553-7390</issn><issn pub-type="epub">1553-7404</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PLGE-RA-1070R5</article-id><article-id pub-id-type="doi">10.1371/journal.pgen.1000847</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Diabetes and Endocrinology</subject><subject>Diabetes and Endocrinology/Type 2 Diabetes</subject><subject>Genetics and Genomics</subject><subject>Genetics and Genomics/Complex Traits</subject><subject>Genetics and Genomics/Genetics of Disease</subject><subject>Genetics and Genomics/Population Genetics</subject></subj-group></article-categories><title-group><article-title>A Genome-Wide Association Study Identifies Susceptibility Variants for Type 2 Diabetes in Han Chinese</article-title><alt-title alt-title-type="running-head">Type 2 Diabetes in Han Chinese</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Tsai</surname><given-names>Fuu-Jen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Yang</surname><given-names>Chi-Fan</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Chen</surname><given-names>Ching-Chu</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chuang</surname><given-names>Lee-Ming</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Chieh-Hsiang</given-names></name><xref ref-type="aff" rid="aff9"><sup>9</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chang</surname><given-names>Chwen-Tzuei</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Tzu-Yuan</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Rong-Hsing</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Shiu</surname><given-names>Chiung-Fang</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yi-Min</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chang</surname><given-names>Chih-Chun</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Pei</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Chien-Hsiun</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fann</surname><given-names>Cathy S. J.</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Yuan-Tsong</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="aff" rid="aff10"><sup>10</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Jer-Yuarn</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="aff" rid="aff11"><sup>11</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>School of Post-Baccalaureate Chinese Medicine, China Medical University, Taichung, Taiwan</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Department of Medical Genetics, Pediatrics and Medical Research, China Medical University Hospital, Taichung, Taiwan</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Department of Biotechnology and Bioinformatics, Asia University, Taichung, Taiwan</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan</addr-line></aff><aff id="aff5"><label>5</label><addr-line>National Genotyping Center, Academia Sinica, Taipei, Taiwan</addr-line></aff><aff id="aff6"><label>6</label><addr-line>Division of Endocrinology and Metabolism, Department of Medicine, China Medical University Hospital, Taichung, Taiwan</addr-line></aff><aff id="aff7"><label>7</label><addr-line>School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan</addr-line></aff><aff id="aff8"><label>8</label><addr-line>Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan</addr-line></aff><aff id="aff9"><label>9</label><addr-line>Department of Internal Medicine, Endocrinology and Metabolism, Chia-Yi Christian Hospital, Chia-Yi, Taiwan</addr-line></aff><aff id="aff10"><label>10</label><addr-line>Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, United States of America</addr-line></aff><aff id="aff11"><label>11</label><addr-line>Graduate Institute of Chinese Medical Science, China Medical University, Taichung, Taiwan</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Visscher</surname><given-names>Peter M.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Queensland Institute of Medical Research, Australia</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>chen0010@ibms.sinica.edu.tw</email> (Y-TC); <email>jywu@ibms.sinica.edu.tw</email> (J-YW)</corresp><fn fn-type="con"><p>Conceived and designed the experiments: YT Chen, JY Wu. Performed the experiments: CF Yang, YM Liu, CC Chang. Analyzed the data: CF Shiu, P Chen, CH Chen, CSJ Fann. Contributed reagents/materials/analysis tools: FJ Tsai, CC Chen, LM Chuang, CH Lu, CT Chang, TY Wang, RH Chen. Wrote the paper: CF Yang, YT Chen, JY Wu.</p></fn></author-notes><pub-date pub-type="collection"><month>2</month><year>2010</year></pub-date><!-- Fake ppub added to accomodate plos workflow change from 03/2008 and 03/2009 --><pub-date pub-type="ppub"><month>2</month><year>2010</year></pub-date><pub-date pub-type="epub"><day>19</day><month>2</month><year>2010</year></pub-date><volume>6</volume><issue>2</issue><elocation-id>e1000847</elocation-id><history><date date-type="received"><day>25</day><month>6</month><year>2009</year></date><date date-type="accepted"><day>18</day><month>1</month><year>2010</year></date></history><permissions><copyright-statement>Tsai et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><p>To investigate the underlying mechanisms of T2D pathogenesis, we looked for diabetes susceptibility genes that increase the risk of type 2 diabetes (T2D) in a Han Chinese population. A two-stage genome-wide association (GWA) study was conducted, in which 995 patients and 894 controls were genotyped using the Illumina HumanHap550-Duo BeadChip for the first genome scan stage. This was further replicated in 1,803 patients and 1,473 controls in stage 2. We found two loci not previously associated with diabetes susceptibility in and around the genes protein tyrosine phosphatase receptor type D (<italic>PTPRD</italic>) (<italic>P</italic>&#x0200a;&#x0003d;&#x0200a;8.54&#x000d7;10<sup>&#x02212;10</sup>; odds ratio &#x0005b;OR&#x0005d;&#x0200a;&#x0003d;&#x0200a;1.57; 95&#x00025; confidence interval &#x0005b;CI&#x0005d;&#x0200a;&#x0003d;&#x0200a;1.36&#x02013;1.82), and serine racemase (<italic>SRR</italic>) (<italic>P</italic>&#x0200a;&#x0003d;&#x0200a;3.06&#x000d7;10<sup>&#x02212;9</sup>; OR&#x0200a;&#x0003d;&#x0200a;1.28; 95&#x00025; CI&#x0200a;&#x0003d;&#x0200a;1.18&#x02013;1.39). We also confirmed that variants in <italic>KCNQ1</italic> were associated with T2D risk, with the strongest signal at rs2237895 (<italic>P</italic>&#x0200a;&#x0003d;&#x0200a;9.65&#x000d7;10<sup>&#x02212;10</sup>; OR&#x0200a;&#x0003d;&#x0200a;1.29, 95&#x00025; CI&#x0200a;&#x0003d;&#x0200a;1.19&#x02013;1.40). By identifying two novel genetic susceptibility loci in a Han Chinese population and confirming the involvement of <italic>KCNQ1</italic>, which was previously reported to be associated with T2D in Japanese and European descent populations, our results may lead to a better understanding of differences in the molecular pathogenesis of T2D among various populations.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>Type 2 diabetes (T2D) is a complex disease that involves many genes and environmental factors. Genome-wide and candidate-gene association studies have thus far identified at least 19 regions containing genes that may confer a risk for T2D. However, most of these studies were conducted with patients of European descent. We studied Chinese patients with T2D and identified two genes, PTPRD and SRR, that were not previously known to be involved in diabetes and are involved in biological pathways different from those implicated in T2D by previous association reports. PTPRD is a protein tyrosine phosphatase and may affect insulin signaling on its target cells. SRR encodes a serine racemase that synthesizes D-serine from L-serine. Both D-serine (coagonist) and the neurotransmitter glutamate bind to NMDA receptors and trigger excitatory neurotransmission in the brain. Glutamate signaling also regulates insulin and glucagon secretion in pancreatic islets. Thus, SRR and D-serine, in addition to regulating insulin and glucagon secretion, may play a role in the etiology of T2D. Our study suggests that, in different patient populations, different genes may confer risks for diabetes. Our findings may lead to a better understanding of the molecular pathogenesis of T2D.</p></abstract><counts><page-count count="9"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Type 2 diabetes (T2D) affects at least 6&#x00025; of the world's population; the worldwide prevalence is expected to double by 2025 <xref ref-type="bibr" rid="pgen.1000847-Zimmet1">&#x0005b;1&#x0005d;</xref>. T2D is a complex disorder that is characterized by hyperglycemia, which results from impaired pancreatic &#x003b2; cell function, decreased insulin action at target tissues, and increased glucose output by the liver <xref ref-type="bibr" rid="pgen.1000847-Stumvoll1">&#x0005b;2&#x0005d;</xref>. Both genetic and environmental factors contribute to the pathogenesis of T2D. The disease is considered to be a polygenic disorder in which each genetic variant confers a partial and additive effect. Only 5&#x00025;&#x02013;10&#x00025; of T2D cases are due to single gene defects; these include maturity-onset diabetes of the young (MODY), insulin resistance syndromes, mitochondrial diabetes, and neonatal diabetes <xref ref-type="bibr" rid="pgen.1000847-Ledermann1">&#x0005b;3&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000847-Fajans1">&#x0005b;5&#x0005d;</xref>. Inherited variations have been identified from studies of monogenic diabetes, and have provided insights into &#x003b2; cell physiology, insulin release, and the action of insulin on target cells <xref ref-type="bibr" rid="pgen.1000847-Moore1">&#x0005b;6&#x0005d;</xref>.</p><p>Much effort has been devoted to finding common T2D genes, including genome-wide linkage, candidate-gene, and genome-wide association studies (GWAS). Whole-genome linkage scans have identified chromosomal regions linked to T2D; however, with the exception of regions 1q <xref ref-type="bibr" rid="pgen.1000847-Langefeld1">&#x0005b;7&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000847-Hsueh1">&#x0005b;13&#x0005d;</xref> and 20q, which have been repeatedly mapped, linkage results vary from study to study <xref ref-type="bibr" rid="pgen.1000847-Bowden1">&#x0005b;14&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000847-Klupa1">&#x0005b;19&#x0005d;</xref>. Candidate-gene studies have provided strong evidence that common variants in the peroxisome proliferator-activated receptor-r (<italic>PPARG</italic>) <xref ref-type="bibr" rid="pgen.1000847-Altshuler1">&#x0005b;20&#x0005d;</xref>, potassium inwardly-rectifying channel J11 (<italic>KCNJ11</italic>) <xref ref-type="bibr" rid="pgen.1000847-Florez1">&#x0005b;21&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000847-Nielsen1">&#x0005b;23&#x0005d;</xref>, transcription factor 2 isoform b (<italic>TCF2</italic>) <xref ref-type="bibr" rid="pgen.1000847-Gudmundsson1">&#x0005b;24&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Winckler1">&#x0005b;25&#x0005d;</xref>, and Wolfram syndrome 1 (<italic>WFS1</italic>) <xref ref-type="bibr" rid="pgen.1000847-Sandhu1">&#x0005b;26&#x0005d;</xref> genes are associated with T2D. These genes all have strong biological links to diabetes, and rare, severe mutations cause monogenic diabetes. GWAS have accelerated the identification of T2D susceptibility genes, expanding the list from three in 2006 to over 20 genes in 2009. There are now at least 19 loci containing genes that increase risk of T2D, including <italic>PPARG</italic><xref ref-type="bibr" rid="pgen.1000847-Scott1">&#x0005b;27&#x0005d;</xref>, <italic>KCNJ11</italic><xref ref-type="bibr" rid="pgen.1000847-Scott1">&#x0005b;27&#x0005d;</xref>, <italic>KCNQ1</italic><xref ref-type="bibr" rid="pgen.1000847-Yasuda1">&#x0005b;28&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Unoki1">&#x0005b;29&#x0005d;</xref>, <italic>CDKAL1</italic><xref ref-type="bibr" rid="pgen.1000847-Scott1">&#x0005b;27&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Unoki1">&#x0005b;29&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000847-Zeggini1">&#x0005b;33&#x0005d;</xref>, <italic>CDKN2A-2B</italic><xref ref-type="bibr" rid="pgen.1000847-Scott1">&#x0005b;27&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Saxena1">&#x0005b;32&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Zeggini1">&#x0005b;33&#x0005d;</xref>, <italic>CDC123-CAMK1D</italic><xref ref-type="bibr" rid="pgen.1000847-Zeggini2">&#x0005b;34&#x0005d;</xref>, <italic>MTNR1B</italic><xref ref-type="bibr" rid="pgen.1000847-BouatiaNaji1">&#x0005b;35&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000847-Prokopenko1">&#x0005b;37&#x0005d;</xref>, <italic>TCF7L2</italic><xref ref-type="bibr" rid="pgen.1000847-1">&#x0005b;31&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Sladek1">&#x0005b;38&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Grant1">&#x0005b;39&#x0005d;</xref>, <italic>TCF2</italic> (<italic>HNF1B</italic>), <italic>HHEX-KIF11-IDE</italic><xref ref-type="bibr" rid="pgen.1000847-Scott1">&#x0005b;27&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Saxena1">&#x0005b;32&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Zeggini1">&#x0005b;33&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Sladek1">&#x0005b;38&#x0005d;</xref>, <italic>JAZF1</italic><xref ref-type="bibr" rid="pgen.1000847-Zeggini2">&#x0005b;34&#x0005d;</xref>, <italic>IGF2BP2</italic><xref ref-type="bibr" rid="pgen.1000847-Scott1">&#x0005b;27&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Unoki1">&#x0005b;29&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Saxena1">&#x0005b;32&#x0005d;</xref>, <italic>SLC30A8</italic><xref ref-type="bibr" rid="pgen.1000847-Scott1">&#x0005b;27&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Saxena1">&#x0005b;32&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Zeggini1">&#x0005b;33&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Sladek1">&#x0005b;38&#x0005d;</xref>, <italic>THADA</italic><xref ref-type="bibr" rid="pgen.1000847-Zeggini2">&#x0005b;34&#x0005d;</xref>, <italic>ADAMTS9</italic><xref ref-type="bibr" rid="pgen.1000847-Zeggini2">&#x0005b;34&#x0005d;</xref>, <italic>WFS1</italic><xref ref-type="bibr" rid="pgen.1000847-Sandhu1">&#x0005b;26&#x0005d;</xref>, <italic>FTO</italic><xref ref-type="bibr" rid="pgen.1000847-Scott1">&#x0005b;27&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-1">&#x0005b;31&#x0005d;</xref>, <italic>NOTCH2</italic><xref ref-type="bibr" rid="pgen.1000847-Zeggini2">&#x0005b;34&#x0005d;</xref>, and <italic>TSPAN8</italic><xref ref-type="bibr" rid="pgen.1000847-Zeggini2">&#x0005b;34&#x0005d;</xref>. Variants in these genes have been identified almost exclusively in populations of European descent, except for <italic>KCNQ1</italic>; individually, these variants confer a modest risk (odds ratio &#x0005b;OR&#x0005d;&#x0200a;&#x0003d;&#x0200a;1.1&#x02013;1.25) of developing T2D. <italic>KCNQ1</italic> was identified as a T2D susceptibility gene in three GWA scans in Japanese individuals, highlighting the need to extend large-scale association efforts to different populations, such as Asian populations <xref ref-type="bibr" rid="pgen.1000847-Yasuda1">&#x0005b;28&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Unoki1">&#x0005b;29&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Takeuchi1">&#x0005b;40&#x0005d;</xref>. The association of other previously reported loci (<italic>CDKAL1</italic>, <italic>CDKN2A-2B</italic>, <italic>IGF2BP2</italic>, <italic>TCF7L2</italic>, <italic>SLC30A8</italic>, <italic>HHEX</italic>, and <italic>KCNJ11</italic>) with T2D were also replicated in the Japanese population <xref ref-type="bibr" rid="pgen.1000847-Unoki1">&#x0005b;29&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Takeuchi1">&#x0005b;40&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Omori1">&#x0005b;41&#x0005d;</xref>.</p><p>To date, a GWA scan for T2D has not been conducted in the Han Chinese population, although the association of some known loci have been confirmed, including <italic>KCNQ1</italic> and <italic>CDKAL1</italic>, <italic>CDKN2A-2B</italic>, <italic>MTNR1B</italic>, <italic>TCF7L2</italic>, <italic>HNF1&#x003b2;</italic>, and <italic>KCNJ11</italic><xref ref-type="bibr" rid="pgen.1000847-Hu1">&#x0005b;42&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000847-Zhou1">&#x0005b;47&#x0005d;</xref>. Therefore, we conducted a two-stage GWA scan for T2D in a Han Chinese population residing in Taiwan. There were a total of 2,798 cases and 2,367 normal controls (995 cases and 894 controls in stage 1, 1,803 cases and 1,473 controls in stage 2). Our accomplished objective was to identify new diabetes susceptibility loci that were associated with increased risk of T2D in a Han Chinese population.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Association analysis</title><p>We conducted a two-stage GWAS to identify genetic variants for T2D in the Han-Chinese residing in Taiwan. In the first stage, an exploratory genome-wide scan, we genotyped 995 T2D cases and 894 population controls using the Illumina Hap550duov3 chip (<xref ref-type="fig" rid="pgen-1000847-g001">Figure 1</xref> and <xref ref-type="supplementary-material" rid="pgen.1000847.s006">Table S1</xref>). For each sample genotyped in this study, the average call rate was 99.92&#x000b1;0.12&#x00025;. After applying stringent quality control criteria, high-quality genotypes for 516,737 SNPs (92.24&#x00025;) were obtained, with an average call rate of 99.92&#x000b1;0.24&#x00025; (<xref ref-type="supplementary-material" rid="pgen.1000847.s007">Table S2</xref>). The results of principal component analysis in stage 1 revealed no evidence for population stratification between T2D cases and controls (<italic>P</italic>&#x0200a;&#x0003d;&#x0200a;0.111, Fst statistics between populations &#x0003c;0.001) (<xref ref-type="supplementary-material" rid="pgen.1000847.s016">Text S1</xref>; <xref ref-type="supplementary-material" rid="pgen.1000847.s001">Figure S1</xref>). Multidimensional scaling analysis using PLINK <xref ref-type="bibr" rid="pgen.1000847-Purcell1">&#x0005b;48&#x0005d;</xref> produced similar results (<xref ref-type="supplementary-material" rid="pgen.1000847.s016">Text S1</xref>; <xref ref-type="supplementary-material" rid="pgen.1000847.s002">Figure S2</xref>). Furthermore, genomic control (GC) with a variance inflation factor &#x003bb;&#x0200a;&#x0003d;&#x0200a;1.078 (trend test) did not substantially change the results of this GWAS (<xref ref-type="supplementary-material" rid="pgen.1000847.s008">Table S3</xref>).</p><fig id="pgen-1000847-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000847.g001</object-id><label>Figure 1</label><caption><title>Graphical summary of T2D GWAS in a Han Chinese population.</title><p>T2D association was determined for SNPs on the Illumina HumanHap550K-Duo chip. The y-axis represents the &#x02212;log<sub>10</sub><italic>P</italic> value and the x-axis represents each of the 516,212 SNPs used in the primary scan of 995 T2D cases and 894 controls.</p></caption><graphic xlink:href="pgen.1000847.g001"/></fig><p>We selected eight SNPs in seven regions: rs9985652 and rs2044844 on 4p13, rs7192960 on 16q23.1, rs7361808 on 20p13, rs1751960 on 10q11.23, rs4845624 on 1q21.3, rs391300 on 17p13.3, and rs648538 on 13q12.3. These SNPs had association <italic>P</italic> values of &#x0003c;10<sup>&#x02212;5</sup> at stage 1 with any of the genotype, allele, trend, dominant, and recessive models for subsequent cross-platform validation using Sequenom (<xref ref-type="table" rid="pgen-1000847-t001">Table 1</xref>; <xref ref-type="supplementary-material" rid="pgen.1000847.s008">Table S3</xref>). For SNPs with weaker associations (<italic>P</italic> value between 10<sup>&#x02212;4</sup> and 10<sup>&#x02212;5</sup>), we searched for novel susceptibility candidates for T2D as implicated by (1) gene function identified by a bioinformatics approach and (2) an animal model showing defects in glucose homeostasis caused by genes within the same subfamily. Therefore, we selected SNP rs17584499 (<italic>P</italic>&#x0200a;&#x0003d;&#x0200a;2.4&#x000d7;10<sup>&#x02212;5</sup> under best model) for further investigation. rs17584499 lies within protein tyrosine phosphatase receptor type D (<italic>PTPRD</italic>). We hypothesized that PTPRD might play a role in the regulation of insulin signaling, because its subfamily members leukocyte common antigen-related (<italic>LAR</italic>) and protein tyrosine phosphatase sigma (<italic>PTPRS</italic>) exhibit defects in glucose homeostasis and insulin sensitivity in knockout and/or transgenic mice <xref ref-type="bibr" rid="pgen.1000847-Ren1">&#x0005b;49&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000847-Batt1">&#x0005b;51&#x0005d;</xref>.</p><table-wrap id="pgen-1000847-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000847.t001</object-id><label>Table 1</label><caption><title>Association results for Type 2 diabetes in Han Chinese.</title></caption><alternatives><graphic id="pgen-1000847-t001-1" xlink:href="pgen.1000847.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td colspan="4" align="left" rowspan="1">Joint anaysis of stage1&#x0002b;2</td></tr><tr><td align="left" rowspan="1" colspan="1">SNP<xref ref-type="table-fn" rid="nt101">a</xref></td><td align="left" rowspan="1" colspan="1">Chr.</td><td align="left" rowspan="1" colspan="1">Nearest gene(s)</td><td align="left" rowspan="1" colspan="1">Risk allele</td><td align="left" rowspan="1" colspan="1">stage</td><td align="left" rowspan="1" colspan="1">RAF (T2D)</td><td align="left" rowspan="1" colspan="1">RAF (NC)</td><td align="left" rowspan="1" colspan="1">OR (95&#x00025; CI)</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> value (trend)</td><td align="left" rowspan="1" colspan="1">OR (95&#x00025; CI)</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> value (trend)</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> value (perm)</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> value (Fisher)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">rs9985652</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">ATP8A1</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.54</td><td align="left" rowspan="1" colspan="1">0.48</td><td align="left" rowspan="1" colspan="1">1.25 (1.10&#x02013;1.42)</td><td align="left" rowspan="1" colspan="1">9.30&#x000d7;10<sup>&#x02212;4</sup></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GRXCR1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0.51</td><td align="left" rowspan="1" colspan="1">0.52</td><td align="left" rowspan="1" colspan="1">0.95 (0.86&#x02013;1.05)</td><td align="left" rowspan="1" colspan="1">0.316</td><td align="left" rowspan="1" colspan="1">1.05 (0.97&#x02013;1.14)</td><td align="left" rowspan="1" colspan="1">0.193</td><td align="left" rowspan="1" colspan="1">0.156</td><td align="left" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2044844</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">ATP8A1</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.53</td><td align="left" rowspan="1" colspan="1">0.48</td><td align="left" rowspan="1" colspan="1">1.24 (1.09&#x02013;1.41)</td><td align="left" rowspan="1" colspan="1">9.30&#x000d7;10<sup>&#x02212;4</sup></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GRXCR1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0.51</td><td align="left" rowspan="1" colspan="1">0.52</td><td align="left" rowspan="1" colspan="1">0.96 (0.87&#x02013;1.06)</td><td align="left" rowspan="1" colspan="1">0.406</td><td align="left" rowspan="1" colspan="1">1.06 (0.98&#x02013;1.14)</td><td align="left" rowspan="1" colspan="1">0.17</td><td align="left" rowspan="1" colspan="1">0.141</td><td align="left" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">rs7192960</td><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">MAF</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.75</td><td align="left" rowspan="1" colspan="1">0.68</td><td align="left" rowspan="1" colspan="1">1.39 (1.20&#x02013;1.61)</td><td align="left" rowspan="1" colspan="1">7.66&#x000d7;10<sup>&#x02212;6</sup></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">WWOX</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0.73</td><td align="left" rowspan="1" colspan="1">0.70</td><td align="left" rowspan="1" colspan="1">1.12 (1.01&#x02013;1.25)</td><td align="left" rowspan="1" colspan="1">0.037</td><td align="left" rowspan="1" colspan="1">1.21 (1.11&#x02013;1.33)</td><td align="left" rowspan="1" colspan="1">1.33&#x000d7;10<sup>&#x02212;5</sup></td><td align="left" rowspan="1" colspan="1">6.82&#x000d7;10<sup>&#x02212;6</sup></td><td align="left" rowspan="1" colspan="1">4.61&#x000d7;10<sup>&#x02212;6</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">rs7361808</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">SIRPA</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.09</td><td align="left" rowspan="1" colspan="1">0.06</td><td align="left" rowspan="1" colspan="1">1.60 (1.24&#x02013;2.05)</td><td align="left" rowspan="1" colspan="1">2.30&#x000d7;10<sup>&#x02212;4</sup></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0.06</td><td align="left" rowspan="1" colspan="1">0.06</td><td align="left" rowspan="1" colspan="1">1.07 (0.87&#x02013;1.31)</td><td align="left" rowspan="1" colspan="1">0.52</td><td align="left" rowspan="1" colspan="1">1.25 (1.07&#x02013;1.47)</td><td align="left" rowspan="1" colspan="1">0.005</td><td align="left" rowspan="1" colspan="1">0.005</td><td align="left" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">rs1751960</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">LYZL1</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.53</td><td align="left" rowspan="1" colspan="1">0.46</td><td align="left" rowspan="1" colspan="1">1.34(1.18&#x02013;1.53)</td><td align="left" rowspan="1" colspan="1">1.13&#x000d7;10<sup>&#x02212;5</sup></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">SVIL</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0.50</td><td align="left" rowspan="1" colspan="1">0.49</td><td align="left" rowspan="1" colspan="1">1.05(0.95&#x02013;1.16)</td><td align="left" rowspan="1" colspan="1">0.317</td><td align="left" rowspan="1" colspan="1">1.15(1.06&#x02013;1.24)</td><td align="left" rowspan="1" colspan="1">3.78&#x000d7;10<sup>&#x02212;4</sup></td><td align="left" rowspan="1" colspan="1">4.05&#x000d7;10<sup>&#x02212;4</sup></td><td align="left" rowspan="1" colspan="1">4.85&#x000d7;10<sup>&#x02212;5</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">rs4845624</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">RORC</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.65</td><td align="left" rowspan="1" colspan="1">0.58</td><td align="left" rowspan="1" colspan="1">1.36 (1.19&#x02013;1.56)</td><td align="left" rowspan="1" colspan="1">5.85&#x000d7;10<sup>&#x02212;6</sup></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TMEM5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0.61</td><td align="left" rowspan="1" colspan="1">0.63</td><td align="left" rowspan="1" colspan="1">0.91 (0.83&#x02013;1.01)</td><td align="left" rowspan="1" colspan="1">0.07</td><td align="left" rowspan="1" colspan="1">1.05 (0.97&#x02013;1.14)</td><td align="left" rowspan="1" colspan="1">0.205</td><td align="left" rowspan="1" colspan="1">0.203</td><td align="left" rowspan="1" colspan="1">6.46&#x000d7;10<sup>&#x02212;6</sup></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>rs391300</bold></td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">SRR</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.69</td><td align="left" rowspan="1" colspan="1">0.63</td><td align="left" rowspan="1" colspan="1">1.31 (1.14&#x02013;1.50)</td><td align="left" rowspan="1" colspan="1">9.00&#x000d7;10<sup>&#x02212;5</sup></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0.68</td><td align="left" rowspan="1" colspan="1">0.62</td><td align="left" rowspan="1" colspan="1">1.26 (1.14&#x02013;1.40)</td><td align="left" rowspan="1" colspan="1">6.55&#x000d7;10<sup>&#x02212;6</sup></td><td align="left" rowspan="1" colspan="1"><bold>1.28 (1.18&#x02013;1.39)</bold></td><td align="left" rowspan="1" colspan="1"><bold>3.06&#x000d7;10<sup>&#x02212;9</sup></bold></td><td align="left" rowspan="1" colspan="1"><bold>1.00&#x000d7;10<sup>&#x02212;8</sup></bold></td><td align="left" rowspan="1" colspan="1"><bold>5.52&#x000d7;10<sup>&#x02212;8</sup></bold><xref ref-type="table-fn" rid="nt104">&#x0002a;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>rs4523957<xref ref-type="table-fn" rid="nt102">b</xref></bold></td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">SRR</td><td align="left" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.71</td><td align="left" rowspan="1" colspan="1">0.65</td><td align="left" rowspan="1" colspan="1">1.30 (1.12&#x02013;1.49)</td><td align="left" rowspan="1" colspan="1">3.24&#x000d7;10<sup>&#x02212;4</sup></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0.68</td><td align="left" rowspan="1" colspan="1">0.63</td><td align="left" rowspan="1" colspan="1">1.26 (1.14&#x02013;1.40)</td><td align="left" rowspan="1" colspan="1">8.22&#x000d7;10<sup>&#x02212;6</sup></td><td align="left" rowspan="1" colspan="1"><bold>1.27 (1.17&#x02013;1.38)</bold></td><td align="left" rowspan="1" colspan="1"><bold>1.44&#x000d7;10<sup>&#x02212;8</sup></bold></td><td align="left" rowspan="1" colspan="1"><bold>3.00&#x000d7;10<sup>&#x02212;8</sup></bold></td><td align="left" rowspan="1" colspan="1"><bold>1.31&#x000d7;10<sup>&#x02212;8</sup></bold><xref ref-type="table-fn" rid="nt104">&#x0002a;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">rs648538</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">KATNAL1</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.67</td><td align="left" rowspan="1" colspan="1">0.61</td><td align="left" rowspan="1" colspan="1">1.28 (1.12&#x02013;1.47)</td><td align="left" rowspan="1" colspan="1">2.92&#x000d7;10<sup>&#x02212;4</sup></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0.65</td><td align="left" rowspan="1" colspan="1">0.66</td><td align="left" rowspan="1" colspan="1">0.96 (0.86&#x02013;1.06)</td><td align="left" rowspan="1" colspan="1">0.407</td><td align="left" rowspan="1" colspan="1">1.07(0.98&#x02013;1.16)</td><td align="left" rowspan="1" colspan="1">0.116</td><td align="left" rowspan="1" colspan="1">0.125</td><td align="left" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>rs17584499</bold></td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">PTPRD</td><td align="left" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.11</td><td align="left" rowspan="1" colspan="1">0.07</td><td align="left" rowspan="1" colspan="1">1.55 (1.23&#x02013;1.94)</td><td align="left" rowspan="1" colspan="1">1.41&#x000d7;10<sup>&#x02212;4</sup></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0.09</td><td align="left" rowspan="1" colspan="1">0.06</td><td align="left" rowspan="1" colspan="1">1.61 (1.33&#x02013;1.95)</td><td align="left" rowspan="1" colspan="1">9.15&#x000d7;10<sup>&#x02212;7</sup></td><td align="left" rowspan="1" colspan="1"><bold>1.57 (1.36&#x02013;1.82)</bold></td><td align="left" rowspan="1" colspan="1"><bold>8.54&#x000d7;10<sup>&#x02212;10</sup></bold></td><td align="left" rowspan="1" colspan="1"><bold>1.00&#x000d7;10<sup>&#x02212;8</sup></bold></td><td align="left" rowspan="1" colspan="1"><bold>3.07&#x000d7;10<sup>&#x02212;9</sup></bold><xref ref-type="table-fn" rid="nt104">&#x0002a;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>rs231361</bold></td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">KCNQ1</td><td align="left" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.85</td><td align="left" rowspan="1" colspan="1">0.81</td><td align="left" rowspan="1" colspan="1">1.39 (1.17&#x02013;1.64)</td><td align="left" rowspan="1" colspan="1">1.49&#x000d7;10<sup>&#x02212;4</sup></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0.83</td><td align="left" rowspan="1" colspan="1">0.79</td><td align="left" rowspan="1" colspan="1">1.26 (1.11&#x02013;1.44)</td><td align="left" rowspan="1" colspan="1">2.85&#x000d7;10<sup>&#x02212;4</sup></td><td align="left" rowspan="1" colspan="1"><bold>1.30 (1.18&#x02013;1.44)</bold></td><td align="left" rowspan="1" colspan="1"><bold>2.89&#x000d7;10<sup>&#x02212;7</sup></bold></td><td align="left" rowspan="1" colspan="1"><bold>3.10&#x000d7;10<sup>&#x02212;7</sup></bold></td><td align="left" rowspan="1" colspan="1"><bold>7.64&#x000d7;10<sup>&#x02212;7</sup></bold><xref ref-type="table-fn" rid="nt104">&#x0002a;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>rs231359<xref ref-type="table-fn" rid="nt102">b</xref></bold></td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">KCNQ1</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.85</td><td align="left" rowspan="1" colspan="1">0.81</td><td align="left" rowspan="1" colspan="1">1.36 (1.14&#x02013;1.61)</td><td align="left" rowspan="1" colspan="1">4.56&#x000d7;10<sup>&#x02212;4</sup></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0.84</td><td align="left" rowspan="1" colspan="1">0.80</td><td align="left" rowspan="1" colspan="1">1.32 (1.17&#x02013;1.51)</td><td align="left" rowspan="1" colspan="1">1.68&#x000d7;10<sup>&#x02212;5</sup></td><td align="left" rowspan="1" colspan="1"><bold>1.33 (1.20&#x02013;1.48)</bold></td><td align="left" rowspan="1" colspan="1"><bold>3.43&#x000d7;10<sup>&#x02212;8</sup></bold></td><td align="left" rowspan="1" colspan="1"><bold>5.00&#x000d7;10<sup>&#x02212;8</sup></bold></td><td align="left" rowspan="1" colspan="1"><bold>1.51&#x000d7;10<sup>&#x02212;7</sup></bold><xref ref-type="table-fn" rid="nt104">&#x0002a;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>rs2237895<xref ref-type="table-fn" rid="nt103">c</xref></bold></td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">KCNQ1</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.40</td><td align="left" rowspan="1" colspan="1">0.35</td><td align="left" rowspan="1" colspan="1">1.28 (1.12&#x02013;1.46)</td><td align="left" rowspan="1" colspan="1">2.92&#x000d7;10<sup>&#x02212;4</sup></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0.39</td><td align="left" rowspan="1" colspan="1">0.33</td><td align="left" rowspan="1" colspan="1">1.30 (1.17&#x02013;1.45)</td><td align="left" rowspan="1" colspan="1">6.46&#x000d7;10<sup>&#x02212;7</sup></td><td align="left" rowspan="1" colspan="1"><bold>1.29 (1.19&#x02013;1.40)</bold></td><td align="left" rowspan="1" colspan="1"><bold>9.65&#x000d7;10<sup>&#x02212;10</sup></bold></td><td align="left" rowspan="1" colspan="1"><bold>1.00&#x000d7;10<sup>&#x02212;8</sup></bold></td><td align="left" rowspan="1" colspan="1"><bold>4.42&#x000d7;10<sup>&#x02212;9</sup></bold><xref ref-type="table-fn" rid="nt104">&#x0002a;</xref></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p><bold><sup>a</sup></bold>SNPs are arranged in order of decreasing <italic>P</italic> value under best statistical model in Stage 1.</p></fn><fn id="nt102"><label/><p><bold><sup>b</sup></bold>Neighboring SNPs also significantly associated with T2D.</p></fn><fn id="nt103"><label/><p><bold><sup>c</sup></bold>Previously reported SNP associated with T2D <sup>28, 29</sup> and validated in our study.</p></fn><fn id="nt104"><label/><p>&#x0002a;Empirical <italic>P</italic> value &#x0003c;10<sup>6</sup> after 10<sup>8</sup> permutations.</p></fn><fn id="nt105"><label/><p>Stage 1(Genome scan) included 995 cases and 894 controls. Stage 2 (replication stage) included 1,803 cases and 1,473 controls. Alleles were indexed to the forward strand of NCBI Build 36. <italic>P</italic> value (trend), <italic>P</italic> value (PC), <italic>P</italic> value (permutation), and <italic>P</italic> value (meta) represent <italic>P</italic> values of trend test, principal component analysis using EIGENSTRAT, permutation, and meta-analysis using Fisher's method, respectively.</p></fn><fn id="nt106"><label/><p>Risk allele, allele with higher frequency in cases compared to controls; RAF (T2D) and RAF (NC), risk allele frequencies in cases and controls, respectively; and OR, odds ratio for risk allele.</p></fn></table-wrap-foot></table-wrap><p>We also evaluated the most significant SNP (rs231361) within <italic>KCNQ1</italic>, which was previously reported to be a diabetes susceptibility gene in a Japanese population, as well as in populations of Korean, Chinese, and European ancestry <xref ref-type="bibr" rid="pgen.1000847-Yasuda1">&#x0005b;28&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Unoki1">&#x0005b;29&#x0005d;</xref>. Together, these ten SNPs&#x02014;the 8 SNPs with association <italic>p</italic>&#x0003c;10<sup>&#x02212;5</sup>, rs17584499, and rs231361&#x02014;were cross-platform validated and yielded consistent results using both Illumina and Sequenom. The concordance rate for stage 1 samples typed on the Illumina and Sequenom platforms was 99.1&#x00025;&#x000b1;0.84&#x00025; (<xref ref-type="supplementary-material" rid="pgen.1000847.s009">Table S4</xref>).</p><p>We took these ten SNPs and an additional 29 neighboring SNPs within the linkage disequilibrium (LD) block forward to replicate in 3,803 additional samples (stage 2; 1,803 cases and 1,473 controls). The average call rate for each sample was 96.13&#x00025;&#x000b1;4.66&#x00025;. After applying stringent quality control criteria, high-quality genotypes for 35 SNPs (89.7&#x00025;) were obtained, with an average call rate of 98.96&#x00025;&#x000b1;0.24&#x00025; (<xref ref-type="supplementary-material" rid="pgen.1000847.s007">Table S2</xref>). Of the ten SNPs selected in stage 1, only three SNPs still showed a strong association in the stage 2 analysis: rs17584499 in <italic>PTPRD</italic> at 9p24.1-p23, rs231359 in <italic>KCNQ1</italic> at 11p15.5, and rs391300 in serine racemase (<italic>SRR</italic>) at 17p13.3 (<xref ref-type="table" rid="pgen-1000847-t001">Table 1</xref>). We were unable to replicate the association between T2D and the remaining seven SNPs in <italic>ATP8A1/GRXCR1</italic>, <italic>MAF/WWOX</italic>, <italic>SIRPA</italic>, <italic>LYZL1/SVIL</italic>, <italic>RORC/TMEM5</italic>, and <italic>KATNAL1</italic> in the stage 2 analysis (<xref ref-type="table" rid="pgen-1000847-t001">Table 1</xref>). Joint analysis of stage 1 and stage 2 data revealed consistent results with stage 2. The most significant associations were found for rs391300, rs17584499, and rs231359 (<xref ref-type="table" rid="pgen-1000847-t001">Table 1</xref>; <xref ref-type="fig" rid="pgen-1000847-g002">Figure 2</xref>). These associations remained significant after calculating <italic>P</italic> values using 10<sup>8</sup> permutations of the disease state labels. Joint association analysis was performed with all of the 2,798 T2D cases and 2,367 controls; this could achieve a power of 0.85 to detect a disease allele with a frequency of 0.15 and an OR of 1.5, assuming a disease prevalence of 0.06, at a significant level of 0.05 (<xref ref-type="supplementary-material" rid="pgen.1000847.s010">Table S5</xref>).</p><fig id="pgen-1000847-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000847.g002</object-id><label>Figure 2</label><caption><title>Regional plots of three significant associations.</title><p>For each of the (A) <italic>PTPRD</italic>, (B) <italic>SRR</italic>, and (C) <italic>KCNQ1</italic> regions, the &#x02212;log<sub>10</sub><italic>P</italic> values for the trend test from the primary scan were plotted as a function of genomic position (NCBI Build 36). The SNPs with the strongest signal and neighboring genotyped SNPs in the joint analysis are denoted by blue diamonds. Green diamonds in the <italic>KCNQ1</italic> region (C) represent reported T2D&#x02013;associated SNPs genotyped in all samples of joint analysis. Estimated recombination rates (right y-axis) based on the Chinese HapMap population was plotted to reflect the local LD structure around the significant SNPs. Gene annotations were taken from NCBI.</p></caption><graphic xlink:href="pgen.1000847.g002"/></fig></sec><sec id="s2b"><title>Identification of two novel T2D loci and confirmation of <italic>KCNQ1</italic> association</title><p>Two previously unknown loci were detected in our joint analysis of GWAS data. The strongest new association signal was found for rs17584499 in intron 10 of <italic>PTPRD</italic> (<italic>P</italic>&#x0200a;&#x0003d;&#x0200a;8.54&#x000d7;10<sup>&#x02212;10</sup> &#x0005b;trend test&#x0005d;; allelic OR&#x0200a;&#x0003d;&#x0200a;1.57, 95&#x00025; confidence interval &#x0005b;CI&#x0005d;&#x0200a;&#x0003d;&#x0200a;1.36&#x02013;1.82) (<xref ref-type="table" rid="pgen-1000847-t001">Table 1</xref>; <xref ref-type="fig" rid="pgen-1000847-g002">Figure 2</xref>). The second strongest signal was found with rs391300 (<italic>P</italic>&#x0200a;&#x0003d;&#x0200a;3.06&#x000d7;10<sup>&#x02212;9</sup> &#x0005b;trend test&#x0005d;; OR&#x0200a;&#x0003d;&#x0200a;1.28, 95&#x00025; CI&#x0200a;&#x0003d;&#x0200a;1.18&#x02013;1.39). The nearby SNP rs4523957 also demonstrated a significant association (<italic>P</italic>&#x0200a;&#x0003d;&#x0200a;1.44&#x000d7;10<sup>&#x02212;8</sup>; OR&#x0200a;&#x0003d;&#x0200a;1.27, 95&#x00025; CI&#x0200a;&#x0003d;&#x0200a;1.17&#x02013;1.38). SNPs rs391300 and rs4523957 were in tight LD with one another (<italic>r</italic><sup>2</sup>&#x0200a;&#x0003d;&#x0200a;0.942 in HapMap HCB), and were located within the serine racemase gene (<italic>SRR</italic>).</p><p>SNP rs231361, located in intron 11 of <italic>KCNQ1</italic>, had a less significant association with T2D, and was selected in stage 1 (<italic>P</italic>&#x0200a;&#x0003d;&#x0200a;1.49&#x000d7;10<sup>&#x02212;4</sup> &#x0005b;trend test&#x0005d;; OR&#x0200a;&#x0003d;&#x0200a;1.39, 95&#x00025; CI&#x0200a;&#x0003d;&#x0200a;1.17&#x02013;1.64) (<xref ref-type="table" rid="pgen-1000847-t001">Table 1</xref>). We further genotyped eight additional SNPs within the same LD block from the HapMap Asian group data: rs231359 yielded a <italic>P</italic> value of 4.56&#x000d7;10<sup>&#x02212;4</sup> with a trend test (OR&#x0200a;&#x0003d;&#x0200a;1.36, 95&#x00025; CI&#x0200a;&#x0003d;&#x0200a;1.14&#x02013;1.61) (<xref ref-type="fig" rid="pgen-1000847-g002">Figure 2</xref>). rs231361 and rs231359 were in strong LD with one another (<italic>r</italic><sup>2</sup>&#x0200a;&#x0003d;&#x0200a;1 in HapMap HCB), and were located approximately 164 kb upstream of SNP rs2237897, which was previously reported to be significantly associated with T2D in a Japanese population <xref ref-type="bibr" rid="pgen.1000847-Yasuda1">&#x0005b;28&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Unoki1">&#x0005b;29&#x0005d;</xref>. We took rs231361, rs231359, and neighboring SNPs within the LD block forward to replicate in stage 2. Joint analysis of stage 1 and stage 2 data revealed that rs231359 had an even stronger association with T2D than did rs231361 (rs231359: <italic>P</italic>&#x0200a;&#x0003d;&#x0200a;3.43&#x000d7;10<sup>&#x02212;8</sup>, OR&#x0200a;&#x0003d;&#x0200a;1.33, 95&#x00025; CI&#x0200a;&#x0003d;&#x0200a;1.2&#x02013;1.48; rs231361: <italic>P</italic>&#x0200a;&#x0003d;&#x0200a;2.89&#x000d7;10<sup>&#x02212;7</sup>, OR&#x0200a;&#x0003d;&#x0200a;1.3, 95&#x00025; CI&#x0200a;&#x0003d;&#x0200a;1.18&#x02013;1.44).</p><p>Additional SNPs that were reported to be significantly associated with T2D in a Japanese population were further genotyped <xref ref-type="bibr" rid="pgen.1000847-Yasuda1">&#x0005b;28&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Unoki1">&#x0005b;29&#x0005d;</xref>. The average call rate for each sample was 99.12&#x00025;&#x000b1;7.21&#x00025;. After applying stringent quality control criteria, we obtained high-quality genotypes with an average call rate of 99.16&#x00025;&#x000b1;0.18&#x00025; (<xref ref-type="supplementary-material" rid="pgen.1000847.s007">Table S2</xref>). SNP rs2237895 showed the strongest association with T2D of all the genotyped SNPs in <italic>KCNQ1</italic> (<italic>P</italic>&#x0200a;&#x0003d;&#x0200a;9.65&#x000d7;10<sup>&#x02212;10</sup>; OR&#x0200a;&#x0003d;&#x0200a;1.29, 95&#x00025; CI&#x0200a;&#x0003d;&#x0200a;1.19&#x02013;1.40) (<xref ref-type="fig" rid="pgen-1000847-g002">Figure 2</xref> and <xref ref-type="supplementary-material" rid="pgen.1000847.s003">Figure S3</xref>; <xref ref-type="supplementary-material" rid="pgen.1000847.s011">Table S6</xref>). Conditioning on the rs2237895, the statistical significance of rs231361 (or rs231359) disappeared. It seems the same underlying biological effect between the 2 SNPs (<xref ref-type="supplementary-material" rid="pgen.1000847.s012">Table S7</xref>).</p><p>Subsequently, we sequenced all of the exons, intron&#x02013;exon boundaries, and up to 1.2 kb of the promoter region of the <italic>KCNQ1</italic> gene in 50 individuals with T2D, and identified 42 polymorphic variations, including one nonsynonymous P448R polymorphism and two novel SNPs with minor allele frequency &#x0003e;0.03. We then genotyped the two novel SNPs and one nonsynonymous polymorphism; however, none of these SNPs showed an association with T2D (<xref ref-type="supplementary-material" rid="pgen.1000847.s011">Table S6</xref>).</p></sec></sec><sec id="s3"><title>Discussion</title><p>Our GWAS for T2D in a Han Chinese population found two previously unreported susceptibility genes. All of the significant variants detected in our study showed modest effects, with an OR between 1.21 and 1.57. Two loci with less-significant associations in our primary scan (stage 1), <italic>PTPRD</italic> and <italic>KCNQ1</italic>, were selected for further replication; both showed compelling evidence of association in joint analysis. The susceptibility loci we identified in this study need to be further replicated in additional populations. Of the 18 loci previously reported to be associated with T2D (with the exception of <italic>KCNQ1</italic>), none of the <italic>P</italic> values for any of the SNPs within or near the genes reached 10<sup>&#x02212;5</sup> using allele, genotype, trend, dominant, or recessive models (<xref ref-type="supplementary-material" rid="pgen.1000847.s013">Table S8</xref>; <xref ref-type="supplementary-material" rid="pgen.1000847.s004">Figure S4</xref>). Three SNPs within <italic>CDKAL1</italic>, <italic>JAZF1</italic>, and <italic>HNF1B</italic> had the lowest <italic>P</italic> values, ranging from 5&#x000d7;10<sup>&#x02212;4</sup> to 10<sup>&#x02212;5</sup>, among the 18 known loci (<xref ref-type="supplementary-material" rid="pgen.1000847.s013">Table S8</xref>). No significant associations were found within these regions in our Han Chinese population.</p><p>The strongest new signal was observed for rs17584499 in <italic>PTPRD</italic>. The overall Fst among 11 HapMap groups for rs17584499 was estimated to be 0.068 <xref ref-type="bibr" rid="pgen.1000847-Wright1">&#x0005b;52&#x0005d;</xref>, which indicated a significant difference in allele frequencies among the populations (<italic>P</italic>&#x0003c;0.0001, chi-square test ) (<xref ref-type="supplementary-material" rid="pgen.1000847.s014">Table S9</xref>). <italic>PTPRD</italic> is widely expressed in tissues, including skeletal muscle and pancreas, and is expressed highest in the brain. <italic>PTPRD</italic>-deficient mice exhibit impaired learning and memory, early growth retardation, neonatal mortality, and posture and motor defects <xref ref-type="bibr" rid="pgen.1000847-Uetani1">&#x0005b;53&#x0005d;</xref>. Multiple mRNA isoforms are expressed by alternative splicing and/or alternative transcription start sites in a developmental and tissue-specific manner <xref ref-type="bibr" rid="pgen.1000847-Pulido1">&#x0005b;54&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Sato1">&#x0005b;55&#x0005d;</xref>. <italic>PTPRD</italic> belongs to the receptor type IIA (R2A) subfamily of protein tyrosine phosphatases (PTPs). The R2A PTP subfamily comprises <italic>LAR</italic>, <italic>PTPRS</italic>, and <italic>PTPRD</italic>. The R2A family has been implicated in neural development, cancer, and diabetes <xref ref-type="bibr" rid="pgen.1000847-Chagnon2">&#x0005b;56&#x0005d;</xref>. Although the complex phenotype including neurological defects seen in knockout mice could obscure the roles of these genes in glucose homeostasis, <italic>LAR</italic>- and <italic>PTPRS</italic>-deficient mice were demonstrated to have altered glucose homeostasis and insulin sensitivity <xref ref-type="bibr" rid="pgen.1000847-Ren1">&#x0005b;49&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000847-Batt1">&#x0005b;51&#x0005d;</xref>. Transgenic mice overexpressing <italic>LAR</italic> in skeletal muscle show whole-body insulin resistance <xref ref-type="bibr" rid="pgen.1000847-Zabolotny1">&#x0005b;57&#x0005d;</xref>. Because R2A subfamily members are structurally very similar <xref ref-type="bibr" rid="pgen.1000847-Pulido1">&#x0005b;54&#x0005d;</xref>, <italic>PTPRD</italic> could play a role in T2D pathogenesis and should be further characterized.</p><p>The second new association locus was found for rs391300 and rs4523957 in the biologically plausible candidate gene <italic>SRR</italic>. <italic>SRR</italic> encodes a serine racemase that synthesizes D-serine from L-serine <xref ref-type="bibr" rid="pgen.1000847-Wolosker1">&#x0005b;58&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Wolosker2">&#x0005b;59&#x0005d;</xref>. D-serine is a physiological co-agonist of the N-methyl D-aspartate (NMDA) class of glutamate receptors, the major excitatory neurotransmitter receptors mediating synaptic neurotransmission in the brain <xref ref-type="bibr" rid="pgen.1000847-DeMiranda1">&#x0005b;60&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Mothet1">&#x0005b;61&#x0005d;</xref>. NMDA receptor activation requires binding of glutamate and D-serine, which plays a neuromodulatory role in NMDA receptor transmission, synaptic plasticity, cell migration, and neurotoxicity <xref ref-type="bibr" rid="pgen.1000847-Wolosker3">&#x0005b;62&#x0005d;</xref>. D-serine and SRR are also present in the pancreas <xref ref-type="bibr" rid="pgen.1000847-Imai1">&#x0005b;63&#x0005d;</xref>. Glutamate signaling functions in peripheral tissues, including the pancreas, and positively modulates secretion of both glucagon and insulin in pancreatic islets <xref ref-type="bibr" rid="pgen.1000847-Gonoi1">&#x0005b;64&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000847-Bertrand1">&#x0005b;66&#x0005d;</xref>. The nearby SNP rs216193 also showed significant association (<italic>P</italic>&#x0200a;&#x0003d;&#x0200a;2.49&#x000d7;10<sup>&#x02212;6</sup>); this SNP resides 3.8 kb upstream from <italic>SRR</italic>, within Smg-6 homolog, nonsense mediated mRNA decay factor (<italic>C. elegans</italic>) (<italic>SMG6</italic>). rs216193 was in tight LD with rs391300 (<italic>r</italic><sup>2</sup>&#x0200a;&#x0003d;&#x0200a;0.942 in HapMap HCB). Based on their biological functions and the association results, neither <italic>SMG6</italic> nor any of the nearby genes <italic>TSR1</italic>, <italic>SGSM2</italic>, <italic>MNT</italic>, and <italic>METT10D</italic> were compelling candidates for association withT2D. However, <italic>SRR</italic> was significantly associated with T2D; thus, we suggest that dysregulation of D-serine could alter glutamate signaling and affect insulin or glucagon secretion in T2D pathogenesis.</p><p>rs7192960 also had a suggestive association with T2D (<italic>P</italic>&#x0200a;&#x0003d;&#x0200a;1.32&#x000d7;10<sup>&#x02212;5</sup>; OR&#x0200a;&#x0003d;&#x0200a;1.21, 95&#x00025; CI&#x0200a;&#x0003d;&#x0200a;1.11&#x02013;1.33). This SNP which lies approximately 211 kb downstream of v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) (<italic>MAF</italic>) and 170 kb downstream of WW domain containing oxidoreductase (<italic>WWOX</italic>). <italic>WWOX</italic> is a tumor suppressor gene that spans the second most common human fragile site FRA16D <xref ref-type="bibr" rid="pgen.1000847-Bednarek1">&#x0005b;67&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Ried1">&#x0005b;68&#x0005d;</xref>, and is disrupted in many tumors, including pancreatic carcinoma <xref ref-type="bibr" rid="pgen.1000847-Bednarek1">&#x0005b;67&#x0005d;</xref>, <xref ref-type="bibr" rid="pgen.1000847-Iliopoulos1">&#x0005b;69&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000847-Yendamuri1">&#x0005b;73&#x0005d;</xref>. <italic>MAF</italic> encodes the transcription factor c-Maf, a member of the Maf family of basic-Zip (bZip) transcription factors. c-Maf is involved in development and differentiation of the lens <xref ref-type="bibr" rid="pgen.1000847-Sakai1">&#x0005b;74&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Kim1">&#x0005b;75&#x0005d;</xref>, kidney <xref ref-type="bibr" rid="pgen.1000847-Imaki1">&#x0005b;76&#x0005d;</xref>, immune system <xref ref-type="bibr" rid="pgen.1000847-Agnello1">&#x0005b;77&#x0005d;</xref>, adipose tissue <xref ref-type="bibr" rid="pgen.1000847-Serria1">&#x0005b;78&#x0005d;</xref>, and pancreas <xref ref-type="bibr" rid="pgen.1000847-Tsuchiya1">&#x0005b;79&#x0005d;</xref>. It is expressed in &#x003b1; cells of the pancreatic islets <xref ref-type="bibr" rid="pgen.1000847-Kataoka1">&#x0005b;80&#x0005d;</xref>, and is a strong transactivator of the glucagon promoter that regulates glucagon gene expression <xref ref-type="bibr" rid="pgen.1000847-Kataoka1">&#x0005b;80&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Gosmain1">&#x0005b;81&#x0005d;</xref>. c-Maf is also associated with early-onset and morbid adult obesity <xref ref-type="bibr" rid="pgen.1000847-Meyre1">&#x0005b;82&#x0005d;</xref>.</p><p>Our GWAS revealed that <italic>KCNQ1</italic>, which was previously reported to be associated with T2D in several populations, was also associated with T2D in a Han Chinese population residing in Taiwan. <italic>KCNQ1</italic> encodes the pore-forming &#x003b1; subunit of a voltage-gated K<sup>&#x0002b;</sup> channel (KvLQT1), which is involved in repolarization of the action potential in cardiac muscle <xref ref-type="bibr" rid="pgen.1000847-Sanguinetti1">&#x0005b;83&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Barhanin1">&#x0005b;84&#x0005d;</xref>. Mutations in <italic>KCNQ1</italic> cause long QT syndrome <xref ref-type="bibr" rid="pgen.1000847-Neyroud1">&#x0005b;85&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Wang2">&#x0005b;86&#x0005d;</xref> and familial atrial fibrillation <xref ref-type="bibr" rid="pgen.1000847-Chen1">&#x0005b;87&#x0005d;</xref>. <italic>KCNQ1</italic> is widely expressed, including in the heart, brain, kidney, liver, intestine, and pancreas <xref ref-type="bibr" rid="pgen.1000847-Lee1">&#x0005b;88&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000847-Chouabe1">&#x0005b;90&#x0005d;</xref>. It is also expressed in pancreatic islets, and blockade of the KvLQT1 channel stimulates insulin secretion in insulin-secreting INS-1 cells <xref ref-type="bibr" rid="pgen.1000847-Ullrich1">&#x0005b;91&#x0005d;</xref>. <italic>KCNQ1</italic> knockout mice have cardiac dysfunctions <xref ref-type="bibr" rid="pgen.1000847-Lee1">&#x0005b;88&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000847-Casimiro1">&#x0005b;92&#x0005d;</xref> and enhanced systemic insulin sensitivity <xref ref-type="bibr" rid="pgen.1000847-Boini1">&#x0005b;93&#x0005d;</xref>. In our study, variants in the coding region did not show an association with T2D. The functional variant(s) could be located in the regulatory element of <italic>KCNQ1</italic>, rather than in the coding region. We did not find an association between either <italic>CDKAL1</italic> or <italic>IGF2BP2</italic> and T2D, in contrast with the results described in a previous study <xref ref-type="bibr" rid="pgen.1000847-Unoki1">&#x0005b;29&#x0005d;</xref>, nor did we find T2D associated with various other genes identified in populations of European descent.</p><p>In conclusion, we identified two previously unknown loci that are associated with T2D in a Han Chinese population, and confirmed the reported association of <italic>KCNQ1</italic> with T2D. The novel T2D risk loci may involve genes that are implicated in insulin sensitivity and control of glucagon and insulin secretion: <italic>PTPRD</italic> may participate in the regulation of insulin action on its target cells, while <italic>SRR</italic> variants may alter glutamate signaling in the pancreas, thus regulating insulin and/or glucagon secretion. Our study suggests that in different patient populations, different genes may confer risks for diabetes, which may lead to a better understanding of the molecular pathogenesis of T2D.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and Methods</title><sec id="s4a"><title>Ethical statement</title><p>The study was approved by the institutional review board and the ethics committee of each institution. Written informed consent was obtained from each participant in accordance with institutional requirements and the Declaration of Helsinki Principles.</p></sec><sec id="s4b"><title>Subject participants</title><p>A total of 2,798 unrelated individuals with T2D, age &#x0003e;20 years, were recruited from China Medical University Hospital (CMUH), Taichung, Taiwan; Chia-Yi Christian Hospital (CYCH), Chia-Yi, Taiwan; and National Taiwan University Hospital (NTU), Taipei, Taiwan. All of the T2D cases were diagnosed according to medical records and fasting plasma glucose levels using American Diabetic Association Criteria. Subjects with type 1 diabetes, gestational diabetes, and maturity-onset diabetes of the young (MODY) were excluded from this study. For the two-stage GWAS, we genotyped 995 T2D cases and 894 controls in the first exploratory genome-wide scan (stage 1). In the replication stage (stage 2), we genotyped selected SNPs in additional samples from 1,803 T2D cases and 1,473 controls. The controls were randomly selected from the Taiwan Han Chinese Cell and Genome Bank <xref ref-type="bibr" rid="pgen.1000847-Pan1">&#x0005b;94&#x0005d;</xref>. The criteria for controls in the association study were (1) no past diagnostic history of T2D, (2) HbA<sub>1C</sub> ranging from 3.4 to 6, and (3) BMI&#x0003c;32. The two control groups were comparable with respect to BMI, gender, age at study, and level of HbA<sub>1C</sub>. All of the participating T2D cases and controls were of Han Chinese origin, which is the origin of 98&#x00025; of the Taiwan population. Details of demographic data are shown in <xref ref-type="supplementary-material" rid="pgen.1000847.s015">Table S10</xref>.</p></sec><sec id="s4c"><title>Genotyping</title><p>Genomic DNA was extracted from peripheral blood using the Puregene DNA isolation kit (Gentra Systems, Minneapolis, MN, USA). In stage 1, whole genome genotyping using the Illumina HumanHap550-Duo BeadChip was performed by deCODE Genetics (Reykjav&#x000ed;k, Iceland). Genotype calling was performed using the standard procedure implemented in BeadStudio (Illumina, Inc., San Diego, CA, USA), with the default parameters suggested by the platform manufacturer. Quality control of genotype data was performed by examining several summary statistics. First, the ratio of loci with heterozygous calls on the X chromosome was calculated to double-check the subject's gender. Total successful call rate and the minor allele frequency of cases and controls were also calculated for each SNP. SNPs were excluded if they: (1) were nonpolymorphic in both cases and controls, (2) had a total call rate &#x0003c;95&#x00025; in the cases and controls combined, (3) had a minor allele frequency &#x0003c;5&#x00025; and a total call rate &#x0003c;99&#x00025; in the cases and controls combined, and (4) had significant distortion from Hardy&#x02013;Weinberg equilibrium in the controls (<italic>P</italic>&#x0003c;10<sup>&#x02212;7</sup>). Genotyping validation was performed using the Sequenom iPLEX assay (Sequenom MassARRAY system; Sequenom, San Diego, CA, USA). In the replication stage (stage 2), SNPs showing significant or suggestive associations with T2D and their neighboring SNPs within the same LD block were genotyped using the Sequenom iPLEX assay. The neighboring SNPs in the same LD were selected from the HapMap Asian (CHB &#x0002b; JPT) group data for fine mapping the significant signal.</p></sec><sec id="s4d"><title>Statistical analysis</title><p>T2D association analysis was carried out to compare allele frequency and genotype distribution between cases and controls using five single-point methods for each SNP: genotype, allele, trend (Cochran&#x02013;Armitage test), dominant, and recessive models. The most significant test statistic obtained from the five models was chosen. SNPs with <italic>P</italic> values less than a&#x0200a;&#x0003d;&#x0200a;2&#x000d7;10<sup>&#x02212;8</sup>, a cut-off for the multiple comparison adjusted by Bonferroni correction, were considered to be significantly associated with the traits. The joint analysis was conducted by combining the data from the stage 1 and 2 samples. We also applied Fisher's method to combine <italic>P</italic> values for joint analysis. The permutation test was carried out genome-wide for 10<sup>6</sup> permutations, in which the phenotypes of subjects were randomly rearranged. For better estimation of empirical <italic>P</italic> values, the top SNPs were reexamined using 10<sup>8</sup> permutations. Each permutation proceeded as follows: (1) the case and control labels were shuffled and redistributed to subjects, and (2) the test statistics of the corresponding association test was calculated based on the shuffled labels. The empirical <italic>P</italic> value was defined as the number of permutations that were at least as extreme as the original divided by the total number of permutations. Detection of possible population stratification that might influence association analysis was carried out using principle component analysis, multidimensional scaling analysis, and genomic control (<xref ref-type="supplementary-material" rid="pgen.1000847.s016">Text S1</xref>). Quantile&#x02013;quantile (Q&#x02013;Q) plots were then used to examine <italic>P</italic> value distributions (<xref ref-type="fig" rid="pgen-1000847-g003">Figure 3</xref> and <xref ref-type="supplementary-material" rid="pgen.1000847.s005">Figure S5</xref>).</p><fig id="pgen-1000847-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000847.g003</object-id><label>Figure 3</label><caption><title>Q&#x02013;Q plot for the trend test.</title><p>Q&#x02013;Q plots are shown for the trend test based on the 516,212 quality SNPs of the initial analysis of 995 cases and 894 controls. The red lines represent the upper and lower boundaries of the 95&#x00025; confidence bands.</p></caption><graphic xlink:href="pgen.1000847.g003"/></fig></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pgen.1000847.s001"><label>Figure S1</label><caption><p>Principle component analysis (PCA) plot. The PCA plot shows the first two principal components, estimated by EIGENSTRAT (Price et al. Nat Genet 38: 904&#x02013;909), based on genotype data from 76,673 SNPs with equal spacing across the human genome. No population stratification between the 995 T2D cases (green x) and 894 controls (red &#x0002b;) was detected (<italic>P</italic>&#x0200a;&#x0003d;&#x0200a;0.111, and Fst statistics between populations &#x0003c;0.001).</p><p>(1.18 MB TIF)</p></caption><media xlink:href="pgen.1000847.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000847.s002"><label>Figure S2</label><caption><p>Multidimensional scaling analysis (MDS) plot. The MDS plot shows the first two principal components, estimated by PLINK (Zheng et al. Am J Hum Genet 81:559&#x02013;575), based on genotype data from 516,212 SNPs. No population stratification between the 995 T2D cases (red) and 894 controls (blue) was detected (IBS group-difference empirical <italic>P</italic>&#x0200a;&#x0003d;&#x0200a;0.192598 for T1: case/control less similar).</p><p>(0.74 MB TIF)</p></caption><media xlink:href="pgen.1000847.s002.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000847.s003"><label>Figure S3</label><caption><p>LD block between rs231361 and rs223787.</p><p>(0.17 MB TIF)</p></caption><media xlink:href="pgen.1000847.s003.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000847.s004"><label>Figure S4</label><caption><p>Comparisons to susceptible regions reported by previous GWAS. For each of the (A) <italic>NOTCH2</italic>, (B) <italic>THADA</italic>, (C) <italic>PPARG</italic>, (D) <italic>IGF2BP2</italic>, (E) <italic>ADAMTS9</italic>, (F) <italic>WFS1</italic>, (G) <italic>CDKAL1</italic>, (H) <italic>JAF1</italic>, (I) <italic>SLC30A8</italic>, (J) <italic>CDKN2AB</italic>, (K) <italic>HHEX</italic>, (L) <italic>CDC123/CAMK1D</italic>, (M) <italic>TCF7L2</italic>, (N) <italic>KCNJ11</italic>, (O) <italic>MTNR1B</italic>, (P) <italic>TSPAN8/LGR5</italic>, (Q) <italic>FTO</italic>, and (R) <italic>TCF</italic> (<italic>HNF1B</italic>) regions, the &#x02212;log<sub>10</sub><italic>P</italic> values from the primary scan are plotted as a function of genomic position (NCBI Build 36). The reported SNPs in previous GWAS are denoted by blue diamonds. Estimated recombination rates (right y-axis) based on the Chinese HapMap population are plotted to reflect the local LD structure around the significant SNPs. Gene annotations and numbers of transcripts were taken from NCBI.</p><p>(4.17 MB TIF)</p></caption><media xlink:href="pgen.1000847.s004.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000847.s005"><label>Figure S5</label><caption><p>Quantile-quantile (QQ) plots. QQ plots are shown for the four association tests, (A) allelic, (B) genotype, (C) dominant, and (D) recessive, based on the 516,212 quality SNPs of the initial analysis of 995 cases and 894 controls. The upper and lower boundaries of the 95&#x00025; confidence bands are represented by the red lines.</p><p>(3.10 MB TIF)</p></caption><media xlink:href="pgen.1000847.s005.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000847.s006"><label>Table S1</label><caption><p>Quality control of the subject participants in stage 1.</p><p>(0.03 MB DOC)</p></caption><media xlink:href="pgen.1000847.s006.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000847.s007"><label>Table S2</label><caption><p>Quality control of the genotyping results.</p><p>(0.03 MB DOC)</p></caption><media xlink:href="pgen.1000847.s007.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000847.s008"><label>Table S3</label><caption><p>Association results in stage 1.</p><p>(0.05 MB DOC)</p></caption><media xlink:href="pgen.1000847.s008.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000847.s009"><label>Table S4</label><caption><p>Concordance rates for the 10 SNPs with significant associations in stage 1.</p><p>(0.05 MB DOC)</p></caption><media xlink:href="pgen.1000847.s009.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000847.s010"><label>Table S5</label><caption><p>Power Calculation using CaTS.</p><p>(0.05 MB DOC)</p></caption><media xlink:href="pgen.1000847.s010.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000847.s011"><label>Table S6</label><caption><p>Association of additional SNPs within KCNQ1 in all T2D cases and controls in the joint analysis.</p><p>(0.06 MB DOC)</p></caption><media xlink:href="pgen.1000847.s011.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000847.s012"><label>Table S7</label><caption><p>Conditional analysis on rs2237895.</p><p>(0.03 MB DOC)</p></caption><media xlink:href="pgen.1000847.s012.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000847.s013"><label>Table S8</label><caption><p>Previously reported loci and SNPs associated with T2D.</p><p>(0.13 MB DOC)</p></caption><media xlink:href="pgen.1000847.s013.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000847.s014"><label>Table S9</label><caption><p>Genotype frequency and allele frequency of rs17584499 (founders only) from HapMap3.</p><p>(0.05 MB DOC)</p></caption><media xlink:href="pgen.1000847.s014.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000847.s015"><label>Table S10</label><caption><p>Clinical characteristics of the subjects.</p><p>(0.04 MB DOC)</p></caption><media xlink:href="pgen.1000847.s015.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1000847.s016"><label>Text S1</label><caption><p>Supplementary methods.</p><p>(0.03 MB DOC)</p></caption><media xlink:href="pgen.1000847.s016.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We would like to thank all of the patients and study personnel who participated in this study. We also thank Ms. Kuan-Ching Lee for handling the samples and Mr. Yan-Hau Chen and Ms. Yi-Jung Lin for their expertise in bioinformatics.</p></ack><ref-list><title>References</title><ref id="pgen.1000847-Zimmet1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmet</surname><given-names>P</given-names></name><name><surname>Alberti</surname><given-names>KG</given-names></name><name><surname>Shaw</surname><given-names>J</given-names></name></person-group><year>2001</year><article-title>Global and societal implications of the diabetes epidemic.</article-title><source>Nature</source><volume>414</volume><fpage>782</fpage><lpage>787</lpage><pub-id pub-id-type="pmid">11742409</pub-id></mixed-citation></ref><ref id="pgen.1000847-Stumvoll1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stumvoll</surname><given-names>M</given-names></name><name><surname>Goldstein</surname><given-names>BJ</given-names></name><name><surname>van Haeften</surname><given-names>TW</given-names></name></person-group><year>2005</year><article-title>Type 2 diabetes: principles of pathogenesis and therapy.</article-title><source>Lancet</source><volume>365</volume><fpage>1333</fpage><lpage>1346</lpage><pub-id pub-id-type="pmid">15823385</pub-id></mixed-citation></ref><ref id="pgen.1000847-Ledermann1"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ledermann</surname><given-names>HM</given-names></name></person-group><year>1995</year><article-title>Maturity-onset diabetes of the young (MODY) at least ten times more common in Europe than previously assumed?</article-title><source>Diabetologia</source><volume>38</volume><fpage>1482</fpage><pub-id pub-id-type="pmid">8786024</pub-id></mixed-citation></ref><ref id="pgen.1000847-Maassen1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maassen</surname><given-names>JA</given-names></name><name><surname>LM</surname><given-names>TH</given-names></name><name><surname>Van Essen</surname><given-names>E</given-names></name><name><surname>Heine</surname><given-names>RJ</given-names></name><name><surname>Nijpels</surname><given-names>G</given-names></name><etal/></person-group><year>2004</year><article-title>Mitochondrial diabetes: molecular mechanisms and clinical presentation.</article-title><source>Diabetes</source><volume>53</volume><issue>Suppl 1</issue><fpage>S103</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">14749274</pub-id></mixed-citation></ref><ref id="pgen.1000847-Fajans1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fajans</surname><given-names>SS</given-names></name><name><surname>Bell</surname><given-names>GI</given-names></name><name><surname>Polonsky</surname><given-names>KS</given-names></name></person-group><year>2001</year><article-title>Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young.</article-title><source>N Engl J Med</source><volume>345</volume><fpage>971</fpage><lpage>980</lpage><pub-id pub-id-type="pmid">11575290</pub-id></mixed-citation></ref><ref id="pgen.1000847-Moore1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>AF</given-names></name><name><surname>Florez</surname><given-names>JC</given-names></name></person-group><year>2008</year><article-title>Genetic susceptibility to type 2 diabetes and implications for antidiabetic therapy.</article-title><source>Annu Rev Med</source><volume>59</volume><fpage>95</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">17937592</pub-id></mixed-citation></ref><ref id="pgen.1000847-Langefeld1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langefeld</surname><given-names>CD</given-names></name><name><surname>Wagenknecht</surname><given-names>LE</given-names></name><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>Williams</surname><given-names>AH</given-names></name><name><surname>Hokanson</surname><given-names>JE</given-names></name><etal/></person-group><year>2004</year><article-title>Linkage of the metabolic syndrome to 1q23-q31 in Hispanic families: the Insulin Resistance Atherosclerosis Study Family Study.</article-title><source>Diabetes</source><volume>53</volume><fpage>1170</fpage><lpage>1174</lpage><pub-id pub-id-type="pmid">15047638</pub-id></mixed-citation></ref><ref id="pgen.1000847-Hanson1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>RL</given-names></name><name><surname>Ehm</surname><given-names>MG</given-names></name><name><surname>Pettitt</surname><given-names>DJ</given-names></name><name><surname>Prochazka</surname><given-names>M</given-names></name><name><surname>Thompson</surname><given-names>DB</given-names></name><etal/></person-group><year>1998</year><article-title>An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians.</article-title><source>Am J Hum Genet</source><volume>63</volume><fpage>1130</fpage><lpage>1138</lpage><pub-id pub-id-type="pmid">9758619</pub-id></mixed-citation></ref><ref id="pgen.1000847-Elbein1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elbein</surname><given-names>SC</given-names></name><name><surname>Hoffman</surname><given-names>MD</given-names></name><name><surname>Teng</surname><given-names>K</given-names></name><name><surname>Leppert</surname><given-names>MF</given-names></name><name><surname>Hasstedt</surname><given-names>SJ</given-names></name></person-group><year>1999</year><article-title>A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians.</article-title><source>Diabetes</source><volume>48</volume><fpage>1175</fpage><lpage>1182</lpage><pub-id pub-id-type="pmid">10331426</pub-id></mixed-citation></ref><ref id="pgen.1000847-Vionnet1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vionnet</surname><given-names>N</given-names></name><name><surname>Hani</surname><given-names>EH</given-names></name><name><surname>Dupont</surname><given-names>S</given-names></name><name><surname>Gallina</surname><given-names>S</given-names></name><name><surname>Francke</surname><given-names>S</given-names></name><etal/></person-group><year>2000</year><article-title>Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24.</article-title><source>Am J Hum Genet</source><volume>67</volume><fpage>1470</fpage><lpage>1480</lpage><pub-id pub-id-type="pmid">11067779</pub-id></mixed-citation></ref><ref id="pgen.1000847-An1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>P</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Weisnagel</surname><given-names>SJ</given-names></name><name><surname>Rice</surname><given-names>T</given-names></name><name><surname>Rankinen</surname><given-names>T</given-names></name><etal/></person-group><year>2003</year><article-title>Genomic scan of glucose and insulin metabolism phenotypes: the HERITAGE Family Study.</article-title><source>Metabolism</source><volume>52</volume><fpage>246</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">12601641</pub-id></mixed-citation></ref><ref id="pgen.1000847-Wiltshire1"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiltshire</surname><given-names>S</given-names></name><name><surname>Hattersley</surname><given-names>AT</given-names></name><name><surname>Hitman</surname><given-names>GA</given-names></name><name><surname>Walker</surname><given-names>M</given-names></name><name><surname>Levy</surname><given-names>JC</given-names></name><etal/></person-group><year>2001</year><article-title>A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q.</article-title><source>Am J Hum Genet</source><volume>69</volume><fpage>553</fpage><lpage>569</lpage><pub-id pub-id-type="pmid">11484155</pub-id></mixed-citation></ref><ref id="pgen.1000847-Hsueh1"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsueh</surname><given-names>WC</given-names></name><name><surname>St Jean</surname><given-names>PL</given-names></name><name><surname>Mitchell</surname><given-names>BD</given-names></name><name><surname>Pollin</surname><given-names>TI</given-names></name><name><surname>Knowler</surname><given-names>WC</given-names></name><etal/></person-group><year>2003</year><article-title>Genome-wide and fine-mapping linkage studies of type 2 diabetes and glucose traits in the Old Order Amish: evidence for a new diabetes locus on chromosome 14q11 and confirmation of a locus on chromosome 1q21-q24.</article-title><source>Diabetes</source><volume>52</volume><fpage>550</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">12540634</pub-id></mixed-citation></ref><ref id="pgen.1000847-Bowden1"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowden</surname><given-names>DW</given-names></name><name><surname>Sale</surname><given-names>M</given-names></name><name><surname>Howard</surname><given-names>TD</given-names></name><name><surname>Qadri</surname><given-names>A</given-names></name><name><surname>Spray</surname><given-names>BJ</given-names></name><etal/></person-group><year>1997</year><article-title>Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy.</article-title><source>Diabetes</source><volume>46</volume><fpage>882</fpage><lpage>886</lpage><pub-id pub-id-type="pmid">9133559</pub-id></mixed-citation></ref><ref id="pgen.1000847-Xiang1"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>T</given-names></name><name><surname>Jia</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><year>2004</year><article-title>Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24.</article-title><source>Diabetes</source><volume>53</volume><fpage>228</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">14693720</pub-id></mixed-citation></ref><ref id="pgen.1000847-Ji1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>L</given-names></name><name><surname>Malecki</surname><given-names>M</given-names></name><name><surname>Warram</surname><given-names>JH</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Rich</surname><given-names>SS</given-names></name><etal/></person-group><year>1997</year><article-title>New susceptibility locus for NIDDM is localized to human chromosome 20q.</article-title><source>Diabetes</source><volume>46</volume><fpage>876</fpage><lpage>881</lpage><pub-id pub-id-type="pmid">9133558</pub-id></mixed-citation></ref><ref id="pgen.1000847-Zouali1"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zouali</surname><given-names>H</given-names></name><name><surname>Hani</surname><given-names>EH</given-names></name><name><surname>Philippi</surname><given-names>A</given-names></name><name><surname>Vionnet</surname><given-names>N</given-names></name><name><surname>Beckmann</surname><given-names>JS</given-names></name><etal/></person-group><year>1997</year><article-title>A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene.</article-title><source>Hum Mol Genet</source><volume>6</volume><fpage>1401</fpage><lpage>1408</lpage><pub-id pub-id-type="pmid">9285775</pub-id></mixed-citation></ref><ref id="pgen.1000847-Ghosh1"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>RM</given-names></name><name><surname>Hauser</surname><given-names>ER</given-names></name><name><surname>Valle</surname><given-names>T</given-names></name><name><surname>Magnuson</surname><given-names>VL</given-names></name><etal/></person-group><year>1999</year><article-title>Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs.</article-title><source>Proc Natl Acad Sci U S A</source><volume>96</volume><fpage>2198</fpage><lpage>2203</lpage><pub-id pub-id-type="pmid">10051618</pub-id></mixed-citation></ref><ref id="pgen.1000847-Klupa1"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klupa</surname><given-names>T</given-names></name><name><surname>Malecki</surname><given-names>MT</given-names></name><name><surname>Pezzolesi</surname><given-names>M</given-names></name><name><surname>Ji</surname><given-names>L</given-names></name><name><surname>Curtis</surname><given-names>S</given-names></name><etal/></person-group><year>2000</year><article-title>Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2.</article-title><source>Diabetes</source><volume>49</volume><fpage>2212</fpage><lpage>2216</lpage><pub-id pub-id-type="pmid">11118028</pub-id></mixed-citation></ref><ref id="pgen.1000847-Altshuler1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Klannemark</surname><given-names>M</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Vohl</surname><given-names>MC</given-names></name><etal/></person-group><year>2000</year><article-title>The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.</article-title><source>Nat Genet</source><volume>26</volume><fpage>76</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">10973253</pub-id></mixed-citation></ref><ref id="pgen.1000847-Florez1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florez</surname><given-names>JC</given-names></name><name><surname>Burtt</surname><given-names>N</given-names></name><name><surname>de Bakker</surname><given-names>PI</given-names></name><name><surname>Almgren</surname><given-names>P</given-names></name><name><surname>Tuomi</surname><given-names>T</given-names></name><etal/></person-group><year>2004</year><article-title>Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region.</article-title><source>Diabetes</source><volume>53</volume><fpage>1360</fpage><lpage>1368</lpage><pub-id pub-id-type="pmid">15111507</pub-id></mixed-citation></ref><ref id="pgen.1000847-Gloyn1"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gloyn</surname><given-names>AL</given-names></name><name><surname>Weedon</surname><given-names>MN</given-names></name><name><surname>Owen</surname><given-names>KR</given-names></name><name><surname>Turner</surname><given-names>MJ</given-names></name><name><surname>Knight</surname><given-names>BA</given-names></name><etal/></person-group><year>2003</year><article-title>Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes.</article-title><source>Diabetes</source><volume>52</volume><fpage>568</fpage><lpage>572</lpage><pub-id pub-id-type="pmid">12540637</pub-id></mixed-citation></ref><ref id="pgen.1000847-Nielsen1"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>EM</given-names></name><name><surname>Hansen</surname><given-names>L</given-names></name><name><surname>Carstensen</surname><given-names>B</given-names></name><name><surname>Echwald</surname><given-names>SM</given-names></name><name><surname>Drivsholm</surname><given-names>T</given-names></name><etal/></person-group><year>2003</year><article-title>The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes.</article-title><source>Diabetes</source><volume>52</volume><fpage>573</fpage><lpage>577</lpage><pub-id pub-id-type="pmid">12540638</pub-id></mixed-citation></ref><ref id="pgen.1000847-Gudmundsson1"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gudmundsson</surname><given-names>J</given-names></name><name><surname>Sulem</surname><given-names>P</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V</given-names></name><name><surname>Bergthorsson</surname><given-names>JT</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><etal/></person-group><year>2007</year><article-title>Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.</article-title><source>Nat Genet</source><volume>39</volume><fpage>977</fpage><lpage>983</lpage><pub-id pub-id-type="pmid">17603485</pub-id></mixed-citation></ref><ref id="pgen.1000847-Winckler1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winckler</surname><given-names>W</given-names></name><name><surname>Weedon</surname><given-names>MN</given-names></name><name><surname>Graham</surname><given-names>RR</given-names></name><name><surname>McCarroll</surname><given-names>SA</given-names></name><name><surname>Purcell</surname><given-names>S</given-names></name><etal/></person-group><year>2007</year><article-title>Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes.</article-title><source>Diabetes</source><volume>56</volume><fpage>685</fpage><lpage>693</lpage><pub-id pub-id-type="pmid">17327436</pub-id></mixed-citation></ref><ref id="pgen.1000847-Sandhu1"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandhu</surname><given-names>MS</given-names></name><name><surname>Weedon</surname><given-names>MN</given-names></name><name><surname>Fawcett</surname><given-names>KA</given-names></name><name><surname>Wasson</surname><given-names>J</given-names></name><name><surname>Debenham</surname><given-names>SL</given-names></name><etal/></person-group><year>2007</year><article-title>Common variants in WFS1 confer risk of type 2 diabetes.</article-title><source>Nat Genet</source><volume>39</volume><fpage>951</fpage><lpage>953</lpage><pub-id pub-id-type="pmid">17603484</pub-id></mixed-citation></ref><ref id="pgen.1000847-Scott1"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>LJ</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><name><surname>Bonnycastle</surname><given-names>LL</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group><year>2007</year><article-title>A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.</article-title><source>Science</source><volume>316</volume><fpage>1341</fpage><lpage>1345</lpage><pub-id pub-id-type="pmid">17463248</pub-id></mixed-citation></ref><ref id="pgen.1000847-Yasuda1"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasuda</surname><given-names>K</given-names></name><name><surname>Miyake</surname><given-names>K</given-names></name><name><surname>Horikawa</surname><given-names>Y</given-names></name><name><surname>Hara</surname><given-names>K</given-names></name><name><surname>Osawa</surname><given-names>H</given-names></name><etal/></person-group><year>2008</year><article-title>Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus.</article-title><source>Nat Genet</source><volume>40</volume><fpage>1092</fpage><lpage>1097</lpage><pub-id pub-id-type="pmid">18711367</pub-id></mixed-citation></ref><ref id="pgen.1000847-Unoki1"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unoki</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Kawaguchi</surname><given-names>T</given-names></name><name><surname>Hara</surname><given-names>K</given-names></name><name><surname>Horikoshi</surname><given-names>M</given-names></name><etal/></person-group><year>2008</year><article-title>SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations.</article-title><source>Nat Genet</source><volume>40</volume><fpage>1098</fpage><lpage>1102</lpage><pub-id pub-id-type="pmid">18711366</pub-id></mixed-citation></ref><ref id="pgen.1000847-Steinthorsdottir1"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinthorsdottir</surname><given-names>V</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Reynisdottir</surname><given-names>I</given-names></name><name><surname>Benediktsson</surname><given-names>R</given-names></name><name><surname>Jonsdottir</surname><given-names>T</given-names></name><etal/></person-group><year>2007</year><article-title>A variant in CDKAL1 influences insulin response and risk of type 2 diabetes.</article-title><source>Nat Genet</source><volume>39</volume><fpage>770</fpage><lpage>775</lpage><pub-id pub-id-type="pmid">17460697</pub-id></mixed-citation></ref><ref id="pgen.1000847-1"><label>31</label><mixed-citation publication-type="journal"><year>2007</year><article-title>Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.</article-title><source>Nature</source><volume>447</volume><fpage>661</fpage><lpage>678</lpage><pub-id pub-id-type="pmid">17554300</pub-id></mixed-citation></ref><ref id="pgen.1000847-Saxena1"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Burtt</surname><given-names>NP</given-names></name><name><surname>de Bakker</surname><given-names>PI</given-names></name><etal/></person-group><year>2007</year><article-title>Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.</article-title><source>Science</source><volume>316</volume><fpage>1331</fpage><lpage>1336</lpage><pub-id pub-id-type="pmid">17463246</pub-id></mixed-citation></ref><ref id="pgen.1000847-Zeggini1"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeggini</surname><given-names>E</given-names></name><name><surname>Weedon</surname><given-names>MN</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name><name><surname>Elliott</surname><given-names>KS</given-names></name><etal/></person-group><year>2007</year><article-title>Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.</article-title><source>Science</source><volume>316</volume><fpage>1336</fpage><lpage>1341</lpage><pub-id pub-id-type="pmid">17463249</pub-id></mixed-citation></ref><ref id="pgen.1000847-Zeggini2"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeggini</surname><given-names>E</given-names></name><name><surname>Scott</surname><given-names>LJ</given-names></name><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name><name><surname>Marchini</surname><given-names>JL</given-names></name><etal/></person-group><year>2008</year><article-title>Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes.</article-title><source>Nat Genet</source><volume>40</volume><fpage>638</fpage><lpage>645</lpage><pub-id pub-id-type="pmid">18372903</pub-id></mixed-citation></ref><ref id="pgen.1000847-BouatiaNaji1"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouatia-Naji</surname><given-names>N</given-names></name><name><surname>Bonnefond</surname><given-names>A</given-names></name><name><surname>Cavalcanti-Proenca</surname><given-names>C</given-names></name><name><surname>Sparso</surname><given-names>T</given-names></name><name><surname>Holmkvist</surname><given-names>J</given-names></name><etal/></person-group><year>2009</year><article-title>A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk.</article-title><source>Nat Genet</source><volume>41</volume><fpage>89</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">19060909</pub-id></mixed-citation></ref><ref id="pgen.1000847-Lyssenko1"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Nagorny</surname><given-names>CL</given-names></name><name><surname>Erdos</surname><given-names>MR</given-names></name><name><surname>Wierup</surname><given-names>N</given-names></name><name><surname>Jonsson</surname><given-names>A</given-names></name><etal/></person-group><year>2009</year><article-title>Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion.</article-title><source>Nat Genet</source><volume>41</volume><fpage>82</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">19060908</pub-id></mixed-citation></ref><ref id="pgen.1000847-Prokopenko1"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prokopenko</surname><given-names>I</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Florez</surname><given-names>JC</given-names></name><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>Soranzo</surname><given-names>N</given-names></name><etal/></person-group><year>2009</year><article-title>Variants in MTNR1B influence fasting glucose levels.</article-title><source>Nat Genet</source><volume>41</volume><fpage>77</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">19060907</pub-id></mixed-citation></ref><ref id="pgen.1000847-Sladek1"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sladek</surname><given-names>R</given-names></name><name><surname>Rocheleau</surname><given-names>G</given-names></name><name><surname>Rung</surname><given-names>J</given-names></name><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><etal/></person-group><year>2007</year><article-title>A genome-wide association study identifies novel risk loci for type 2 diabetes.</article-title><source>Nature</source><volume>445</volume><fpage>881</fpage><lpage>885</lpage><pub-id pub-id-type="pmid">17293876</pub-id></mixed-citation></ref><ref id="pgen.1000847-Grant1"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>SF</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Reynisdottir</surname><given-names>I</given-names></name><name><surname>Benediktsson</surname><given-names>R</given-names></name><name><surname>Manolescu</surname><given-names>A</given-names></name><etal/></person-group><year>2006</year><article-title>Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.</article-title><source>Nat Genet</source><volume>38</volume><fpage>320</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">16415884</pub-id></mixed-citation></ref><ref id="pgen.1000847-Takeuchi1"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>F</given-names></name><name><surname>Serizawa</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Fujisawa</surname><given-names>T</given-names></name><name><surname>Nakashima</surname><given-names>E</given-names></name><etal/></person-group><year>2009</year><article-title>Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population.</article-title><source>Diabetes</source><volume>58</volume><fpage>1690</fpage><lpage>1699</lpage><pub-id pub-id-type="pmid">19401414</pub-id></mixed-citation></ref><ref id="pgen.1000847-Omori1"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omori</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Hirose</surname><given-names>H</given-names></name><name><surname>Kashiwagi</surname><given-names>A</given-names></name><etal/></person-group><year>2008</year><article-title>Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population.</article-title><source>Diabetes</source><volume>57</volume><fpage>791</fpage><lpage>795</lpage><pub-id pub-id-type="pmid">18162508</pub-id></mixed-citation></ref><ref id="pgen.1000847-Hu1"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group><year>2009</year><article-title>Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese population.</article-title><source>Diabetologia</source><volume>52</volume><fpage>1322</fpage><lpage>1325</lpage><pub-id pub-id-type="pmid">19308350</pub-id></mixed-citation></ref><ref id="pgen.1000847-Wu1"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Loos</surname><given-names>RJ</given-names></name><name><surname>Yu</surname><given-names>Z</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><etal/></person-group><year>2008</year><article-title>Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population.</article-title><source>Diabetes</source><volume>57</volume><fpage>2834</fpage><lpage>2842</lpage><pub-id pub-id-type="pmid">18633108</pub-id></mixed-citation></ref><ref id="pgen.1000847-Chang1"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>YC</given-names></name><name><surname>Chang</surname><given-names>TJ</given-names></name><name><surname>Jiang</surname><given-names>YD</given-names></name><name><surname>Kuo</surname><given-names>SS</given-names></name><name><surname>Lee</surname><given-names>KC</given-names></name><etal/></person-group><year>2007</year><article-title>Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population.</article-title><source>Diabetes</source><volume>56</volume><fpage>2631</fpage><lpage>2637</lpage><pub-id pub-id-type="pmid">17579206</pub-id></mixed-citation></ref><ref id="pgen.1000847-Ronn1"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronn</surname><given-names>T</given-names></name><name><surname>Wen</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Lu</surname><given-names>B</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><etal/></person-group><year>2009</year><article-title>A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals.</article-title><source>Diabetologia</source><volume>52</volume><fpage>830</fpage><lpage>833</lpage><pub-id pub-id-type="pmid">19241057</pub-id></mixed-citation></ref><ref id="pgen.1000847-Wang1"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Bao</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><etal/></person-group><year>2009</year><article-title>Common variants of hepatocyte nuclear factor 1beta are associated with type 2 diabetes in a Chinese population.</article-title><source>Diabetes</source><volume>58</volume><fpage>1023</fpage><lpage>1027</lpage><pub-id pub-id-type="pmid">19168595</pub-id></mixed-citation></ref><ref id="pgen.1000847-Zhou1"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><etal/></person-group><year>2009</year><article-title>The E23K variation in the KCNJ11 gene is associated with type 2 diabetes in Chinese and East Asian population.</article-title><source>J Hum Genet</source><volume>54</volume><fpage>433</fpage><lpage>435</lpage><pub-id pub-id-type="pmid">19498446</pub-id></mixed-citation></ref><ref id="pgen.1000847-Purcell1"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Neale</surname><given-names>B</given-names></name><name><surname>Todd-Brown</surname><given-names>K</given-names></name><name><surname>Thomas</surname><given-names>L</given-names></name><name><surname>Ferreira</surname><given-names>MA</given-names></name><etal/></person-group><year>2007</year><article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses.</article-title><source>Am J Hum Genet</source><volume>81</volume><fpage>559</fpage><lpage>575</lpage><pub-id pub-id-type="pmid">17701901</pub-id></mixed-citation></ref><ref id="pgen.1000847-Ren1"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>JM</given-names></name><name><surname>Li</surname><given-names>PM</given-names></name><name><surname>Zhang</surname><given-names>WR</given-names></name><name><surname>Sweet</surname><given-names>LJ</given-names></name><name><surname>Cline</surname><given-names>G</given-names></name><etal/></person-group><year>1998</year><article-title>Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis.</article-title><source>Diabetes</source><volume>47</volume><fpage>493</fpage><lpage>497</lpage><pub-id pub-id-type="pmid">9519761</pub-id></mixed-citation></ref><ref id="pgen.1000847-Chagnon1"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chagnon</surname><given-names>MJ</given-names></name><name><surname>Elchebly</surname><given-names>M</given-names></name><name><surname>Uetani</surname><given-names>N</given-names></name><name><surname>Dombrowski</surname><given-names>L</given-names></name><name><surname>Cheng</surname><given-names>A</given-names></name><etal/></person-group><year>2006</year><article-title>Altered glucose homeostasis in mice lacking the receptor protein tyrosine phosphatase sigma.</article-title><source>Can J Physiol Pharmacol</source><volume>84</volume><fpage>755</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">16998539</pub-id></mixed-citation></ref><ref id="pgen.1000847-Batt1"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batt</surname><given-names>J</given-names></name><name><surname>Asa</surname><given-names>S</given-names></name><name><surname>Fladd</surname><given-names>C</given-names></name><name><surname>Rotin</surname><given-names>D</given-names></name></person-group><year>2002</year><article-title>Pituitary, pancreatic and gut neuroendocrine defects in protein tyrosine phosphatase-sigma-deficient mice.</article-title><source>Mol Endocrinol</source><volume>16</volume><fpage>155</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">11773446</pub-id></mixed-citation></ref><ref id="pgen.1000847-Wright1"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>S</given-names></name></person-group><year>1951</year><article-title>The genetical structure of populations.</article-title><source>Annals of Eugenics</source><volume>15</volume><fpage>323</fpage><lpage>354</lpage></mixed-citation></ref><ref id="pgen.1000847-Uetani1"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uetani</surname><given-names>N</given-names></name><name><surname>Kato</surname><given-names>K</given-names></name><name><surname>Ogura</surname><given-names>H</given-names></name><name><surname>Mizuno</surname><given-names>K</given-names></name><name><surname>Kawano</surname><given-names>K</given-names></name><etal/></person-group><year>2000</year><article-title>Impaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient mice.</article-title><source>Embo J</source><volume>19</volume><fpage>2775</fpage><lpage>2785</lpage><pub-id pub-id-type="pmid">10856223</pub-id></mixed-citation></ref><ref id="pgen.1000847-Pulido1"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pulido</surname><given-names>R</given-names></name><name><surname>Serra-Pages</surname><given-names>C</given-names></name><name><surname>Tang</surname><given-names>M</given-names></name><name><surname>Streuli</surname><given-names>M</given-names></name></person-group><year>1995</year><article-title>The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases: multiple human LAR, PTP delta, and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LAR-interacting protein LIP.1.</article-title><source>Proc Natl Acad Sci U S A</source><volume>92</volume><fpage>11686</fpage><lpage>11690</lpage><pub-id pub-id-type="pmid">8524829</pub-id></mixed-citation></ref><ref id="pgen.1000847-Sato1"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Nagayama</surname><given-names>K</given-names></name><name><surname>Arai</surname><given-names>Y</given-names></name><name><surname>Ito</surname><given-names>N</given-names></name><etal/></person-group><year>2005</year><article-title>Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer.</article-title><source>Genes Chromosomes Cancer</source><volume>44</volume><fpage>405</fpage><lpage>414</lpage><pub-id pub-id-type="pmid">16114034</pub-id></mixed-citation></ref><ref id="pgen.1000847-Chagnon2"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chagnon</surname><given-names>MJ</given-names></name><name><surname>Uetani</surname><given-names>N</given-names></name><name><surname>Tremblay</surname><given-names>ML</given-names></name></person-group><year>2004</year><article-title>Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases.</article-title><source>Biochem Cell Biol</source><volume>82</volume><fpage>664</fpage><lpage>675</lpage><pub-id pub-id-type="pmid">15674434</pub-id></mixed-citation></ref><ref id="pgen.1000847-Zabolotny1"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zabolotny</surname><given-names>JM</given-names></name><name><surname>Kim</surname><given-names>YB</given-names></name><name><surname>Peroni</surname><given-names>OD</given-names></name><name><surname>Kim</surname><given-names>JK</given-names></name><name><surname>Pani</surname><given-names>MA</given-names></name><etal/></person-group><year>2001</year><article-title>Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance.</article-title><source>Proc Natl Acad Sci U S A</source><volume>98</volume><fpage>5187</fpage><lpage>5192</lpage><pub-id pub-id-type="pmid">11309481</pub-id></mixed-citation></ref><ref id="pgen.1000847-Wolosker1"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolosker</surname><given-names>H</given-names></name><name><surname>Blackshaw</surname><given-names>S</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name></person-group><year>1999</year><article-title>Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission.</article-title><source>Proc Natl Acad Sci U S A</source><volume>96</volume><fpage>13409</fpage><lpage>13414</lpage><pub-id pub-id-type="pmid">10557334</pub-id></mixed-citation></ref><ref id="pgen.1000847-Wolosker2"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolosker</surname><given-names>H</given-names></name><name><surname>Sheth</surname><given-names>KN</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Mothet</surname><given-names>JP</given-names></name><name><surname>Brady</surname><given-names>RO</given-names><suffix>Jr</suffix></name><etal/></person-group><year>1999</year><article-title>Purification of serine racemase: biosynthesis of the neuromodulator D-serine.</article-title><source>Proc Natl Acad Sci U S A</source><volume>96</volume><fpage>721</fpage><lpage>725</lpage><pub-id pub-id-type="pmid">9892700</pub-id></mixed-citation></ref><ref id="pgen.1000847-DeMiranda1"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Miranda</surname><given-names>J</given-names></name><name><surname>Panizzutti</surname><given-names>R</given-names></name><name><surname>Foltyn</surname><given-names>VN</given-names></name><name><surname>Wolosker</surname><given-names>H</given-names></name></person-group><year>2002</year><article-title>Cofactors of serine racemase that physiologically stimulate the synthesis of the N-methyl-D-aspartate (NMDA) receptor coagonist D-serine.</article-title><source>Proc Natl Acad Sci U S A</source><volume>99</volume><fpage>14542</fpage><lpage>14547</lpage><pub-id pub-id-type="pmid">12393813</pub-id></mixed-citation></ref><ref id="pgen.1000847-Mothet1"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mothet</surname><given-names>JP</given-names></name><name><surname>Parent</surname><given-names>AT</given-names></name><name><surname>Wolosker</surname><given-names>H</given-names></name><name><surname>Brady</surname><given-names>RO</given-names><suffix>Jr</suffix></name><name><surname>Linden</surname><given-names>DJ</given-names></name><etal/></person-group><year>2000</year><article-title>D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor.</article-title><source>Proc Natl Acad Sci U S A</source><volume>97</volume><fpage>4926</fpage><lpage>4931</lpage><pub-id pub-id-type="pmid">10781100</pub-id></mixed-citation></ref><ref id="pgen.1000847-Wolosker3"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolosker</surname><given-names>H</given-names></name><name><surname>Dumin</surname><given-names>E</given-names></name><name><surname>Balan</surname><given-names>L</given-names></name><name><surname>Foltyn</surname><given-names>VN</given-names></name></person-group><year>2008</year><article-title>D-amino acids in the brain: D-serine in neurotransmission and neurodegeneration.</article-title><source>Febs J</source><volume>275</volume><fpage>3514</fpage><lpage>3526</lpage><pub-id pub-id-type="pmid">18564180</pub-id></mixed-citation></ref><ref id="pgen.1000847-Imai1"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>K</given-names></name><name><surname>Fukushima</surname><given-names>T</given-names></name><name><surname>Santa</surname><given-names>T</given-names></name><name><surname>Homma</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><etal/></person-group><year>1998</year><article-title>Whole body autoradiographic study on the distribution of 14C-D-serine administered intravenously to rats.</article-title><source>Amino Acids</source><volume>15</volume><fpage>351</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">9891759</pub-id></mixed-citation></ref><ref id="pgen.1000847-Gonoi1"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonoi</surname><given-names>T</given-names></name><name><surname>Mizuno</surname><given-names>N</given-names></name><name><surname>Inagaki</surname><given-names>N</given-names></name><name><surname>Kuromi</surname><given-names>H</given-names></name><name><surname>Seino</surname><given-names>Y</given-names></name><etal/></person-group><year>1994</year><article-title>Functional neuronal ionotropic glutamate receptors are expressed in the non-neuronal cell line MIN6.</article-title><source>J Biol Chem</source><volume>269</volume><fpage>16989</fpage><lpage>16992</lpage><pub-id pub-id-type="pmid">8006003</pub-id></mixed-citation></ref><ref id="pgen.1000847-Inagaki1"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inagaki</surname><given-names>N</given-names></name><name><surname>Kuromi</surname><given-names>H</given-names></name><name><surname>Gonoi</surname><given-names>T</given-names></name><name><surname>Okamoto</surname><given-names>Y</given-names></name><name><surname>Ishida</surname><given-names>H</given-names></name><etal/></person-group><year>1995</year><article-title>Expression and role of ionotropic glutamate receptors in pancreatic islet cells.</article-title><source>Faseb J</source><volume>9</volume><fpage>686</fpage><lpage>691</lpage><pub-id pub-id-type="pmid">7768362</pub-id></mixed-citation></ref><ref id="pgen.1000847-Bertrand1"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertrand</surname><given-names>G</given-names></name><name><surname>Gross</surname><given-names>R</given-names></name><name><surname>Puech</surname><given-names>R</given-names></name><name><surname>Loubatieres-Mariani</surname><given-names>MM</given-names></name><name><surname>Bockaert</surname><given-names>J</given-names></name></person-group><year>1993</year><article-title>Glutamate stimulates glucagon secretion via an excitatory amino acid receptor of the AMPA subtype in rat pancreas.</article-title><source>Eur J Pharmacol</source><volume>237</volume><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">7689469</pub-id></mixed-citation></ref><ref id="pgen.1000847-Bednarek1"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bednarek</surname><given-names>AK</given-names></name><name><surname>Laflin</surname><given-names>KJ</given-names></name><name><surname>Daniel</surname><given-names>RL</given-names></name><name><surname>Liao</surname><given-names>Q</given-names></name><name><surname>Hawkins</surname><given-names>KA</given-names></name><etal/></person-group><year>2000</year><article-title>WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.</article-title><source>Cancer Res</source><volume>60</volume><fpage>2140</fpage><lpage>2145</lpage><pub-id pub-id-type="pmid">10786676</pub-id></mixed-citation></ref><ref id="pgen.1000847-Ried1"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ried</surname><given-names>K</given-names></name><name><surname>Finnis</surname><given-names>M</given-names></name><name><surname>Hobson</surname><given-names>L</given-names></name><name><surname>Mangelsdorf</surname><given-names>M</given-names></name><name><surname>Dayan</surname><given-names>S</given-names></name><etal/></person-group><year>2000</year><article-title>Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells.</article-title><source>Hum Mol Genet</source><volume>9</volume><fpage>1651</fpage><lpage>1663</lpage><pub-id pub-id-type="pmid">10861292</pub-id></mixed-citation></ref><ref id="pgen.1000847-Iliopoulos1"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iliopoulos</surname><given-names>D</given-names></name><name><surname>Guler</surname><given-names>G</given-names></name><name><surname>Han</surname><given-names>SY</given-names></name><name><surname>Johnston</surname><given-names>D</given-names></name><name><surname>Druck</surname><given-names>T</given-names></name><etal/></person-group><year>2005</year><article-title>Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.</article-title><source>Oncogene</source><volume>24</volume><fpage>1625</fpage><lpage>1633</lpage><pub-id pub-id-type="pmid">15674328</pub-id></mixed-citation></ref><ref id="pgen.1000847-Kuroki1"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuroki</surname><given-names>T</given-names></name><name><surname>Yendamuri</surname><given-names>S</given-names></name><name><surname>Trapasso</surname><given-names>F</given-names></name><name><surname>Matsuyama</surname><given-names>A</given-names></name><name><surname>Aqeilan</surname><given-names>RI</given-names></name><etal/></person-group><year>2004</year><article-title>The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis.</article-title><source>Clin Cancer Res</source><volume>10</volume><fpage>2459</fpage><lpage>2465</lpage><pub-id pub-id-type="pmid">15073125</pub-id></mixed-citation></ref><ref id="pgen.1000847-Paige1"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paige</surname><given-names>AJ</given-names></name><name><surname>Taylor</surname><given-names>KJ</given-names></name><name><surname>Taylor</surname><given-names>C</given-names></name><name><surname>Hillier</surname><given-names>SG</given-names></name><name><surname>Farrington</surname><given-names>S</given-names></name><etal/></person-group><year>2001</year><article-title>WWOX: a candidate tumor suppressor gene involved in multiple tumor types.</article-title><source>Proc Natl Acad Sci U S A</source><volume>98</volume><fpage>11417</fpage><lpage>11422</lpage><pub-id pub-id-type="pmid">11572989</pub-id></mixed-citation></ref><ref id="pgen.1000847-Kuroki2"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuroki</surname><given-names>T</given-names></name><name><surname>Trapasso</surname><given-names>F</given-names></name><name><surname>Shiraishi</surname><given-names>T</given-names></name><name><surname>Alder</surname><given-names>H</given-names></name><name><surname>Mimori</surname><given-names>K</given-names></name><etal/></person-group><year>2002</year><article-title>Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma.</article-title><source>Cancer Res</source><volume>62</volume><fpage>2258</fpage><lpage>2260</lpage><pub-id pub-id-type="pmid">11956080</pub-id></mixed-citation></ref><ref id="pgen.1000847-Yendamuri1"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yendamuri</surname><given-names>S</given-names></name><name><surname>Kuroki</surname><given-names>T</given-names></name><name><surname>Trapasso</surname><given-names>F</given-names></name><name><surname>Henry</surname><given-names>AC</given-names></name><name><surname>Dumon</surname><given-names>KR</given-names></name><etal/></person-group><year>2003</year><article-title>WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer.</article-title><source>Cancer Res</source><volume>63</volume><fpage>878</fpage><lpage>881</lpage><pub-id pub-id-type="pmid">12591741</pub-id></mixed-citation></ref><ref id="pgen.1000847-Sakai1"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>M</given-names></name><name><surname>Imaki</surname><given-names>J</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Ogata</surname><given-names>A</given-names></name><name><surname>Matsushima-Hibaya</surname><given-names>Y</given-names></name><etal/></person-group><year>1997</year><article-title>Rat maf related genes: specific expression in chondrocytes, lens and spinal cord.</article-title><source>Oncogene</source><volume>14</volume><fpage>745</fpage><lpage>750</lpage><pub-id pub-id-type="pmid">9038383</pub-id></mixed-citation></ref><ref id="pgen.1000847-Kim1"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JI</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Ho</surname><given-names>IC</given-names></name><name><surname>Grusby</surname><given-names>MJ</given-names></name><name><surname>Glimcher</surname><given-names>LH</given-names></name></person-group><year>1999</year><article-title>Requirement for the c-Maf transcription factor in crystallin gene regulation and lens development.</article-title><source>Proc Natl Acad Sci U S A</source><volume>96</volume><fpage>3781</fpage><lpage>3785</lpage><pub-id pub-id-type="pmid">10097114</pub-id></mixed-citation></ref><ref id="pgen.1000847-Imaki1"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imaki</surname><given-names>J</given-names></name><name><surname>Tsuchiya</surname><given-names>K</given-names></name><name><surname>Mishima</surname><given-names>T</given-names></name><name><surname>Onodera</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>JI</given-names></name><etal/></person-group><year>2004</year><article-title>Developmental contribution of c-maf in the kidney: distribution and developmental study of c-maf mRNA in normal mice kidney and histological study of c-maf knockout mice kidney and liver.</article-title><source>Biochem Biophys Res Commun</source><volume>320</volume><fpage>1323</fpage><lpage>1327</lpage><pub-id pub-id-type="pmid">15249232</pub-id></mixed-citation></ref><ref id="pgen.1000847-Agnello1"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agnello</surname><given-names>D</given-names></name><name><surname>Lankford</surname><given-names>CS</given-names></name><name><surname>Bream</surname><given-names>J</given-names></name><name><surname>Morinobu</surname><given-names>A</given-names></name><name><surname>Gadina</surname><given-names>M</given-names></name><etal/></person-group><year>2003</year><article-title>Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights.</article-title><source>J Clin Immunol</source><volume>23</volume><fpage>147</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">12797537</pub-id></mixed-citation></ref><ref id="pgen.1000847-Serria1"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serria</surname><given-names>MS</given-names></name><name><surname>Ikeda</surname><given-names>H</given-names></name><name><surname>Omoteyama</surname><given-names>K</given-names></name><name><surname>Hirokawa</surname><given-names>J</given-names></name><name><surname>Nishi</surname><given-names>S</given-names></name><etal/></person-group><year>2003</year><article-title>Regulation and differential expression of the c-maf gene in differentiating cultured cells.</article-title><source>Biochem Biophys Res Commun</source><volume>310</volume><fpage>318</fpage><lpage>326</lpage><pub-id pub-id-type="pmid">14521912</pub-id></mixed-citation></ref><ref id="pgen.1000847-Tsuchiya1"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchiya</surname><given-names>M</given-names></name><name><surname>Taniguchi</surname><given-names>S</given-names></name><name><surname>Yasuda</surname><given-names>K</given-names></name><name><surname>Nitta</surname><given-names>K</given-names></name><name><surname>Maeda</surname><given-names>A</given-names></name><etal/></person-group><year>2006</year><article-title>Potential roles of large mafs in cell lineages and developing pancreas.</article-title><source>Pancreas</source><volume>32</volume><fpage>408</fpage><lpage>416</lpage><pub-id pub-id-type="pmid">16670624</pub-id></mixed-citation></ref><ref id="pgen.1000847-Kataoka1"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kataoka</surname><given-names>K</given-names></name><name><surname>Shioda</surname><given-names>S</given-names></name><name><surname>Ando</surname><given-names>K</given-names></name><name><surname>Sakagami</surname><given-names>K</given-names></name><name><surname>Handa</surname><given-names>H</given-names></name><etal/></person-group><year>2004</year><article-title>Differentially expressed Maf family transcription factors, c-Maf and MafA, activate glucagon and insulin gene expression in pancreatic islet alpha- and beta-cells.</article-title><source>J Mol Endocrinol</source><volume>32</volume><fpage>9</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">14765989</pub-id></mixed-citation></ref><ref id="pgen.1000847-Gosmain1"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gosmain</surname><given-names>Y</given-names></name><name><surname>Avril</surname><given-names>I</given-names></name><name><surname>Mamin</surname><given-names>A</given-names></name><name><surname>Philippe</surname><given-names>J</given-names></name></person-group><year>2007</year><article-title>Pax-6 and c-Maf functionally interact with the alpha-cell-specific DNA element G1 in vivo to promote glucagon gene expression.</article-title><source>J Biol Chem</source><volume>282</volume><fpage>35024</fpage><lpage>35034</lpage><pub-id pub-id-type="pmid">17901057</pub-id></mixed-citation></ref><ref id="pgen.1000847-Meyre1"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyre</surname><given-names>D</given-names></name><name><surname>Delplanque</surname><given-names>J</given-names></name><name><surname>Chevre</surname><given-names>JC</given-names></name><name><surname>Lecoeur</surname><given-names>C</given-names></name><name><surname>Lobbens</surname><given-names>S</given-names></name><etal/></person-group><year>2009</year><article-title>Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations.</article-title><source>Nat Genet</source><volume>41</volume><fpage>157</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">19151714</pub-id></mixed-citation></ref><ref id="pgen.1000847-Sanguinetti1"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanguinetti</surname><given-names>MC</given-names></name><name><surname>Curran</surname><given-names>ME</given-names></name><name><surname>Zou</surname><given-names>A</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Spector</surname><given-names>PS</given-names></name><etal/></person-group><year>1996</year><article-title>Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel.</article-title><source>Nature</source><volume>384</volume><fpage>80</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">8900283</pub-id></mixed-citation></ref><ref id="pgen.1000847-Barhanin1"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barhanin</surname><given-names>J</given-names></name><name><surname>Lesage</surname><given-names>F</given-names></name><name><surname>Guillemare</surname><given-names>E</given-names></name><name><surname>Fink</surname><given-names>M</given-names></name><name><surname>Lazdunski</surname><given-names>M</given-names></name><etal/></person-group><year>1996</year><article-title>K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current.</article-title><source>Nature</source><volume>384</volume><fpage>78</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">8900282</pub-id></mixed-citation></ref><ref id="pgen.1000847-Neyroud1"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neyroud</surname><given-names>N</given-names></name><name><surname>Tesson</surname><given-names>F</given-names></name><name><surname>Denjoy</surname><given-names>I</given-names></name><name><surname>Leibovici</surname><given-names>M</given-names></name><name><surname>Donger</surname><given-names>C</given-names></name><etal/></person-group><year>1997</year><article-title>A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome.</article-title><source>Nat Genet</source><volume>15</volume><fpage>186</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">9020846</pub-id></mixed-citation></ref><ref id="pgen.1000847-Wang2"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Curran</surname><given-names>ME</given-names></name><name><surname>Splawski</surname><given-names>I</given-names></name><name><surname>Burn</surname><given-names>TC</given-names></name><name><surname>Millholland</surname><given-names>JM</given-names></name><etal/></person-group><year>1996</year><article-title>Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias.</article-title><source>Nat Genet</source><volume>12</volume><fpage>17</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">8528244</pub-id></mixed-citation></ref><ref id="pgen.1000847-Chen1"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YH</given-names></name><name><surname>Xu</surname><given-names>SJ</given-names></name><name><surname>Bendahhou</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>XL</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><year>2003</year><article-title>KCNQ1 gain-of-function mutation in familial atrial fibrillation.</article-title><source>Science</source><volume>299</volume><fpage>251</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">12522251</pub-id></mixed-citation></ref><ref id="pgen.1000847-Lee1"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>MP</given-names></name><name><surname>Ravenel</surname><given-names>JD</given-names></name><name><surname>Hu</surname><given-names>RJ</given-names></name><name><surname>Lustig</surname><given-names>LR</given-names></name><name><surname>Tomaselli</surname><given-names>G</given-names></name><etal/></person-group><year>2000</year><article-title>Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice.</article-title><source>J Clin Invest</source><volume>106</volume><fpage>1447</fpage><lpage>1455</lpage><pub-id pub-id-type="pmid">11120752</pub-id></mixed-citation></ref><ref id="pgen.1000847-Demolombe1"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demolombe</surname><given-names>S</given-names></name><name><surname>Franco</surname><given-names>D</given-names></name><name><surname>de Boer</surname><given-names>P</given-names></name><name><surname>Kuperschmidt</surname><given-names>S</given-names></name><name><surname>Roden</surname><given-names>D</given-names></name><etal/></person-group><year>2001</year><article-title>Differential expression of KvLQT1 and its regulator IsK in mouse epithelia.</article-title><source>Am J Physiol Cell Physiol</source><volume>280</volume><fpage>C359</fpage><lpage>372</lpage><pub-id pub-id-type="pmid">11208532</pub-id></mixed-citation></ref><ref id="pgen.1000847-Chouabe1"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chouabe</surname><given-names>C</given-names></name><name><surname>Neyroud</surname><given-names>N</given-names></name><name><surname>Guicheney</surname><given-names>P</given-names></name><name><surname>Lazdunski</surname><given-names>M</given-names></name><name><surname>Romey</surname><given-names>G</given-names></name><etal/></person-group><year>1997</year><article-title>Properties of KvLQT1 K&#x0002b; channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias.</article-title><source>Embo J</source><volume>16</volume><fpage>5472</fpage><lpage>5479</lpage><pub-id pub-id-type="pmid">9312006</pub-id></mixed-citation></ref><ref id="pgen.1000847-Ullrich1"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ullrich</surname><given-names>S</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Ranta</surname><given-names>F</given-names></name><name><surname>Wittekindt</surname><given-names>OH</given-names></name><name><surname>Ris</surname><given-names>F</given-names></name><etal/></person-group><year>2005</year><article-title>Effects of I(Ks) channel inhibitors in insulin-secreting INS-1 cells.</article-title><source>Pflugers Arch</source><volume>451</volume><fpage>428</fpage><lpage>436</lpage><pub-id pub-id-type="pmid">16133261</pub-id></mixed-citation></ref><ref id="pgen.1000847-Casimiro1"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casimiro</surname><given-names>MC</given-names></name><name><surname>Knollmann</surname><given-names>BC</given-names></name><name><surname>Ebert</surname><given-names>SN</given-names></name><name><surname>Vary</surname><given-names>JC</given-names><suffix>Jr</suffix></name><name><surname>Greene</surname><given-names>AE</given-names></name><etal/></person-group><year>2001</year><article-title>Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen Syndrome.</article-title><source>Proc Natl Acad Sci U S A</source><volume>98</volume><fpage>2526</fpage><lpage>2531</lpage><pub-id pub-id-type="pmid">11226272</pub-id></mixed-citation></ref><ref id="pgen.1000847-Boini1"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boini</surname><given-names>KM</given-names></name><name><surname>Graf</surname><given-names>D</given-names></name><name><surname>Hennige</surname><given-names>AM</given-names></name><name><surname>Koka</surname><given-names>S</given-names></name><name><surname>Kempe</surname><given-names>DS</given-names></name><etal/></person-group><year>2009</year><article-title>Enhanced insulin sensitivity of gene-targeted mice lacking functional KCNQ1.</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><volume>296</volume><fpage>R1695</fpage><lpage>1701</lpage><pub-id pub-id-type="pmid">19369585</pub-id></mixed-citation></ref><ref id="pgen.1000847-Pan1"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>WH</given-names></name><name><surname>Fann</surname><given-names>CS</given-names></name><name><surname>Wu</surname><given-names>JY</given-names></name><name><surname>Hung</surname><given-names>YT</given-names></name><name><surname>Ho</surname><given-names>MS</given-names></name><etal/></person-group><year>2006</year><article-title>Han Chinese cell and genome bank in Taiwan: purpose, design and ethical considerations.</article-title><source>HumHered</source><volume>61</volume><fpage>27</fpage><lpage>30</lpage></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p>This study was supported by Academia Sinica Genomic Medicine Multicenter Study; National Research Program for Genomic Medicine, National Science Council, Taiwan (National Clinical Core, NSC97-3112-B-001-014; and National Genotyping Center, NSC97-3112-B-001-015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>